KR20120082272A - Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds - Google Patents
Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds Download PDFInfo
- Publication number
- KR20120082272A KR20120082272A KR1020110003667A KR20110003667A KR20120082272A KR 20120082272 A KR20120082272 A KR 20120082272A KR 1020110003667 A KR1020110003667 A KR 1020110003667A KR 20110003667 A KR20110003667 A KR 20110003667A KR 20120082272 A KR20120082272 A KR 20120082272A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- oxo
- formula
- methyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008199 coating composition Substances 0.000 title claims abstract description 48
- 239000012855 volatile organic compound Substances 0.000 title abstract description 25
- 230000000845 anti-microbial effect Effects 0.000 title abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 176
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 73
- 239000002131 composite material Substances 0.000 claims abstract description 60
- 229920005989 resin Polymers 0.000 claims abstract description 50
- 239000011347 resin Substances 0.000 claims abstract description 50
- 239000011230 binding agent Substances 0.000 claims abstract description 39
- -1 polyol compound Chemical class 0.000 claims description 84
- 239000010936 titanium Substances 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 33
- 239000000126 substance Substances 0.000 claims description 32
- 229920005862 polyol Polymers 0.000 claims description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 18
- 229910052710 silicon Inorganic materials 0.000 claims description 18
- 229910052719 titanium Inorganic materials 0.000 claims description 18
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 12
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 239000010703 silicon Substances 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- 229920000180 alkyd Polymers 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229920001400 block copolymer Polymers 0.000 claims description 5
- 229920005604 random copolymer Polymers 0.000 claims description 5
- JZLWSRCQCPAUDP-UHFFFAOYSA-N 1,3,5-triazine-2,4,6-triamine;urea Chemical compound NC(N)=O.NC1=NC(N)=NC(N)=N1 JZLWSRCQCPAUDP-UHFFFAOYSA-N 0.000 claims description 4
- NTSHDDNFTOLRAO-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-7-[4-(2-methylprop-2-enoyl)piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1CN(C(=O)C(=C)C)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 NTSHDDNFTOLRAO-UHFFFAOYSA-N 0.000 claims description 4
- PUECWLFDJFIKIE-UHFFFAOYSA-N 1-ethyl-6,8-difluoro-7-[4-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl]-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C(C)N1C=C(C(C2=CC(=C(C(=C12)F)N1CC(N(CC1)CC(COC(C(=C)C)=O)O)C)F)=O)C(=O)O PUECWLFDJFIKIE-UHFFFAOYSA-N 0.000 claims description 4
- NNPNLRNQYUIRCX-UHFFFAOYSA-N 1-ethyl-6-fluoro-7-[4-[2-hydroxy-3-(4-methylphenyl)sulfonyloxypropyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N(CC1)CCN1CC(O)COS(=O)(=O)C1=CC=C(C)C=C1 NNPNLRNQYUIRCX-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 229910052914 metal silicate Inorganic materials 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- KHTCWSRDHSRETB-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-7-[4-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1(CC1)N1C=C(C(C2=CC(=C(C=C12)N1CCN(CC1)CC(COC(C(=C)C)=O)O)F)=O)C(=O)O KHTCWSRDHSRETB-UHFFFAOYSA-N 0.000 claims description 3
- 239000004925 Acrylic resin Substances 0.000 claims description 3
- 229920000178 Acrylic resin Polymers 0.000 claims description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 3
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 claims description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 3
- 229920000877 Melamine resin Polymers 0.000 claims description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 239000003822 epoxy resin Substances 0.000 claims description 3
- CYKDLUMZOVATFT-UHFFFAOYSA-N ethenyl acetate;prop-2-enoic acid Chemical compound OC(=O)C=C.CC(=O)OC=C CYKDLUMZOVATFT-UHFFFAOYSA-N 0.000 claims description 3
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- 150000002596 lactones Chemical class 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229920000647 polyepoxide Polymers 0.000 claims description 3
- 229910000077 silane Inorganic materials 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims description 3
- UIERETOOQGIECD-ONEGZZNKSA-N tiglic acid Chemical compound C\C=C(/C)C(O)=O UIERETOOQGIECD-ONEGZZNKSA-N 0.000 claims description 3
- LGCHXRUYLNDSSG-UHFFFAOYSA-N 1-ethyl-6-fluoro-7-[4-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(CC(O)COC(=O)C(C)=C)CC1 LGCHXRUYLNDSSG-UHFFFAOYSA-N 0.000 claims description 2
- NEXCCKANLCHQRB-UHFFFAOYSA-N 8-ethyl-2-[4-[2-hydroxy-3-(4-nonylphenoxy)propyl]piperazin-1-yl]-5-oxopyrido[2,3-d]pyrimidine-6-carboxylic acid Chemical compound C1=CC(CCCCCCCCC)=CC=C1OCC(O)CN1CCN(C=2N=C3C(C(C(C(O)=O)=CN3CC)=O)=CN=2)CC1 NEXCCKANLCHQRB-UHFFFAOYSA-N 0.000 claims description 2
- 125000003172 aldehyde group Chemical group 0.000 claims description 2
- QHIWVLPBUQWDMQ-UHFFFAOYSA-N butyl prop-2-enoate;methyl 2-methylprop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(=O)C(C)=C.CCCCOC(=O)C=C QHIWVLPBUQWDMQ-UHFFFAOYSA-N 0.000 claims description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960003675 diethadione Drugs 0.000 claims 1
- 150000002605 large molecules Chemical class 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 230000000274 adsorptive effect Effects 0.000 abstract description 5
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 208000008842 sick building syndrome Diseases 0.000 abstract description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 35
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 29
- 238000002360 preparation method Methods 0.000 description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000010521 absorption reaction Methods 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- 239000000654 additive Substances 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 230000000996 additive effect Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000002270 dispersing agent Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000003381 stabilizer Substances 0.000 description 14
- 239000002562 thickening agent Substances 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 11
- 239000000377 silicon dioxide Substances 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 10
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 230000000704 physical effect Effects 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 229920005822 acrylic binder Polymers 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- 150000003077 polyols Chemical class 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000004115 Sodium Silicate Substances 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000003973 paint Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 6
- 229910052911 sodium silicate Inorganic materials 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- YPOXGDJGKBXRFP-UHFFFAOYSA-N pyrimidine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC=N1 YPOXGDJGKBXRFP-UHFFFAOYSA-N 0.000 description 4
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004566 building material Substances 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- SLBOQBILGNEPEB-UHFFFAOYSA-N 1-chloroprop-2-enylbenzene Chemical compound C=CC(Cl)C1=CC=CC=C1 SLBOQBILGNEPEB-UHFFFAOYSA-N 0.000 description 2
- SNMURDBHCOIPBK-UHFFFAOYSA-N 1-ethyl-6-fluoro-4-oxo-7-(4-prop-2-enoylpiperazin-1-yl)quinoline-3-carboxylic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C(=O)C=C)CC1 SNMURDBHCOIPBK-UHFFFAOYSA-N 0.000 description 2
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 2
- IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 description 2
- BXIQMZOHPLKJPV-UHFFFAOYSA-N 2-(1,1,2,2,3,3,4,4,5,7,7,7-dodecafluoroheptoxymethyl)oxirane Chemical compound FC(F)(F)CC(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)OCC1CO1 BXIQMZOHPLKJPV-UHFFFAOYSA-N 0.000 description 2
- SPMYYWZTCLZLQV-UHFFFAOYSA-N 2-[[5-methoxy-2-[4-methoxy-2-(oxiran-2-ylmethyl)phenoxy]phenyl]methyl]oxirane Chemical compound C1OC1CC1=CC(OC)=CC=C1OC1=CC=C(OC)C=C1CC1CO1 SPMYYWZTCLZLQV-UHFFFAOYSA-N 0.000 description 2
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- YCAZALSUJDPQPP-UHFFFAOYSA-N 4-oxo-3h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2C(=O)C(C(=O)O)C=NC2=C1 YCAZALSUJDPQPP-UHFFFAOYSA-N 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 2
- KOKZNSHXLWQAAT-UHFFFAOYSA-N 8-ethyl-2-[4-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl]piperazin-1-yl]-5-oxopyrido[2,3-d]pyrimidine-6-carboxylic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCN(CC(O)COC(=O)C(C)=C)CC1 KOKZNSHXLWQAAT-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- YMNIGPXBWZKMKZ-UHFFFAOYSA-N C=1C=CC=CC=1OCCCCCCCCCCC1CO1 Chemical compound C=1C=CC=CC=1OCCCCCCCCCCC1CO1 YMNIGPXBWZKMKZ-UHFFFAOYSA-N 0.000 description 2
- YEECBGZZIWGSJO-UHFFFAOYSA-N CC1CN(CCN1CC(CC(=O)CC(CC(=O)CC2CO2)O)O)C3=C(C(=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)C)F Chemical compound CC1CN(CCN1CC(CC(=O)CC(CC(=O)CC2CO2)O)O)C3=C(C(=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)C)F YEECBGZZIWGSJO-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000282988 Capreolus Species 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical group 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- NOQXXYIGRPAZJC-UHFFFAOYSA-N oxiran-2-ylmethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1OC1 NOQXXYIGRPAZJC-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- XPEMPJFPRCHICU-UHFFFAOYSA-N (1-tert-butylcyclohexyl) prop-2-enoate Chemical compound C=CC(=O)OC1(C(C)(C)C)CCCCC1 XPEMPJFPRCHICU-UHFFFAOYSA-N 0.000 description 1
- QEQBMZQFDDDTPN-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy benzenecarboperoxoate Chemical compound CC(C)(C)OOOC(=O)C1=CC=CC=C1 QEQBMZQFDDDTPN-UHFFFAOYSA-N 0.000 description 1
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- QKDHBVNJCZBTMR-UHFFFAOYSA-N 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Chemical compound C1CNC(C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1F QKDHBVNJCZBTMR-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- KSLSZOOZWRMSAP-UHFFFAOYSA-N 2-[(4-chlorophenoxy)methyl]oxirane Chemical compound C1=CC(Cl)=CC=C1OCC1OC1 KSLSZOOZWRMSAP-UHFFFAOYSA-N 0.000 description 1
- AVKQYWUBGXNBCW-UHFFFAOYSA-N 2-[(4-nonylphenoxy)methyl]oxirane Chemical compound C1=CC(CCCCCCCCC)=CC=C1OCC1OC1 AVKQYWUBGXNBCW-UHFFFAOYSA-N 0.000 description 1
- DHKVCYCWBUNNQH-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,5,7-tetrahydropyrazolo[3,4-c]pyridin-6-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)C=NN2 DHKVCYCWBUNNQH-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- KCCIMXJIZJBZPX-UHFFFAOYSA-N 2-pent-4-enyloxirane Chemical compound C=CCCCC1CO1 KCCIMXJIZJBZPX-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- PEQIPONKALEJBS-UHFFFAOYSA-N 7-[4-[(4-ethenylphenyl)methyl]piperazin-1-yl]-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N(CC1)CCN1CC1=CC=C(C=C)C=C1 PEQIPONKALEJBS-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- ZBJJDYGJCNTNTH-UHFFFAOYSA-N Betahistine mesilate Chemical group CS(O)(=O)=O.CS(O)(=O)=O.CNCCC1=CC=CC=N1 ZBJJDYGJCNTNTH-UHFFFAOYSA-N 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- UPIYXCQZCKSJJX-UHFFFAOYSA-N CCCCOCC=C(C)C(N)=O Chemical compound CCCCOCC=C(C)C(N)=O UPIYXCQZCKSJJX-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- GXBYFVGCMPJVJX-UHFFFAOYSA-N Epoxybutene Chemical compound C=CC1CO1 GXBYFVGCMPJVJX-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- AIJTTZAVMXIJGM-UHFFFAOYSA-N Grepafloxacin Chemical compound C1CNC(C)CN1C(C(=C1C)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 AIJTTZAVMXIJGM-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 244000128833 Mimulus luteus Species 0.000 description 1
- CNCOEDDPFOAUMB-UHFFFAOYSA-N N-Methylolacrylamide Chemical compound OCNC(=O)C=C CNCOEDDPFOAUMB-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000228153 Penicillium citrinum Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- KXEBLAPZMOQCKO-UHFFFAOYSA-N lomefloxacin hydrochloride Chemical compound Cl.FC1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1 KXEBLAPZMOQCKO-UHFFFAOYSA-N 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WFKDPJRCBCBQNT-UHFFFAOYSA-N n,2-dimethylprop-2-enamide Chemical compound CNC(=O)C(C)=C WFKDPJRCBCBQNT-UHFFFAOYSA-N 0.000 description 1
- UTSYWKJYFPPRAP-UHFFFAOYSA-N n-(butoxymethyl)prop-2-enamide Chemical compound CCCCOCNC(=O)C=C UTSYWKJYFPPRAP-UHFFFAOYSA-N 0.000 description 1
- SFMJNHNUOVADRW-UHFFFAOYSA-N n-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Chemical compound C1=C(NC(=O)C=C)C(C)=CC=C1N1C(=O)C=CC2=C1C1=CC(C=3C=CC(NS(C)(=O)=O)=CC=3)=CC=C1N=C2 SFMJNHNUOVADRW-UHFFFAOYSA-N 0.000 description 1
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- JOHZPMXAZQZXHR-UHFFFAOYSA-N pipemidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCNCC1 JOHZPMXAZQZXHR-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/65—Additives macromolecular
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
- C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/61—Additives non-macromolecular inorganic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2237—Oxides; Hydroxides of metals of titanium
- C08K2003/2241—Titanium dioxide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Plant Pathology (AREA)
- Inorganic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
본 발명은 도료 조성물에 관한 것으로, 본 발명에 따른 항균성 화합물, 실리카-티타니아 복합화합물 및 바인더 수지를 포함하는 도료 조성물에 관한 것이다.
본 발명에 따른 도료 조성물은 항균 활성, 조습성 및 휘발성 유기화합물의 흡착 분해 효능이 우수하여, 새집 증후군을 예방하는 등 상기 효과가 요구되는 다양한 분야에 유용하게 적용할 수 있다.The present invention relates to a coating composition, and to a coating composition comprising an antimicrobial compound, a silica-titania composite compound and a binder resin according to the present invention.
The coating composition according to the present invention is excellent in antimicrobial activity, humidity control and adsorptive decomposition efficacy of volatile organic compounds, and can be usefully applied to various fields requiring the above effects such as preventing sick house syndrome.
Description
본 발명은 도료 조성물에 관한 것이다.The present invention relates to a coating composition.
최근 환경 및 위생에 대한 높은 관심과 생활 양식의 고급화에 따라, 주거환경의 위생, 건축물의 실내공기, 세균에 의한 유해성 등에 대한 관심이 고조되고 있다.Recently, with high interest in environment and hygiene and high quality of life, interest in hygiene of residential environment, indoor air of buildings, and harmfulness by bacteria have increased.
특히 난냉방 효율의 향상과 에너지의 효율적인 이용을 목적으로 건물의 밀폐성이 강조되고 있는데, 그에 따라 세균, 곰팡이 등이 왕성하게 번식하게 되고, 그로 인해 천식 등의 기관지 질환, 아토피성 피부염 등의 알러지 질환 등이 증가하고 있다. 또한, 실내 공간에 설치되는 각종 건축 내장재에서 휘발성 유기화합물(Volatile Organic Compounds, VOCs)이 발생하게 되고, 그로 인한 새집 증후군(NBS, New Building Syndrome) 등이 큰 문제점으로 대두되고 있다.Particularly, the sealing property of buildings is emphasized for the purpose of improving the efficiency of refrigeration and the efficient use of energy. As a result, bacteria and fungi are multiplying, resulting in allergic diseases such as bronchial diseases such as asthma and atopic dermatitis. The back is increasing. In addition, volatile organic compounds (VOCs) are generated in various interior materials installed in the interior space, and new building syndrome (NBS) is emerging as a major problem.
그에 따라 항균 활성을 가지면서도 휘발성 유기화합물 등을 흡착 분해할 수 있는 기능성 건축 자재에 대한 수요가 증가하고 있으며, 그와 함께 다양한 기능성을 부여한 건축 자재에 대한 연구가 활발히 이루어지고 있다.Accordingly, the demand for functional building materials capable of adsorbing and decomposing volatile organic compounds while having antimicrobial activity is increasing, and researches on building materials having various functionalities have been actively conducted.
상기 건축자재, 특히 도료 등에는 유기계 항균물질(예: 4급 암모늄염, 트리아진계, 벤즈이미다졸, 트리클로산, 클로로헥시딘, 치아졸계 등)을 바인더 수지와 혼합하는 방법이 이용된다. 그러나, 상기 예와 같은 유기계 항균물질은 자체적인 독성이 있을 뿐만 아니라, 내열성이 약하기 때문에 빛과 고온에 장시간 노출될 경우 항균 효능이 저감되는 문제점이 있다.In the building materials, especially paints, a method of mixing an organic antimicrobial material (for example, quaternary ammonium salt, triazine, benzimidazole, triclosan, chlorohexidine, thiazole, etc.) with a binder resin is used. However, the organic antimicrobial material as described above has a problem in that the antimicrobial efficacy is reduced when exposed to light and high temperature for a long time due to its own toxicity and heat resistance.
상기한 한계를 극복하기 위하여, 무기계 세라믹 항균 착체를 바인더 수지와 단순 혼합하여 사용하는 방법이 널리 이용되고 있다. 그러나 이러한 방법 역시 수분과 접촉할 경우 화학적으로 항균 활성이 저하되는 문제점이 있다.In order to overcome the above limitations, a method of simply mixing an inorganic ceramic antimicrobial complex with a binder resin is widely used. However, this method also has a problem in that the antimicrobial activity is lowered chemically in contact with water.
한편, 습도는 계절에 따라 적절한 범위 내에서 관리되어야 한다. 즉, 습도가 적정 범위를 벗어나 실내가 건조해지면 인체 점막의 건조 증상을 일으켜 호흡기로 흡입한 미생물 등의 분진을 인체 밖으로 충분히 배출할 수 없어 방어 기능이 저하된다. 반대로 습도가 과할 경우 결로를 발생시키고 곰팡이 발생에 좋은 여건이 형성되어 건물 내부를 오염시키게 된다. On the other hand, humidity should be managed within an appropriate range according to the season. In other words, if the humidity is out of the proper range and the room is dried, the symptoms of drying of the mucous membrane of the human body causes the dust, such as microorganisms inhaled into the respiratory organs can not be sufficiently discharged out of the human body, the defense function is reduced. On the contrary, if the humidity is excessive, condensation will occur, and a good condition for mold development will be formed, which will contaminate the inside of the building.
그에 따라, 도료 조성물에 자율 조습성 등을 부여하기 위해 실리카 등의 무기 성분을 첨가하는 방법이 이용되고 있으나, 그에 따른 효과가 미미하여 이에 대한 보완의 절실히 요구되고 있는 실정이다.Accordingly, a method of adding an inorganic component such as silica in order to impart autonomous humidity control to the coating composition is used, but the effect thereof is insignificant, and the situation is urgently required to compensate for this.
이에 본 발명은 항균 활성이 우수하면서도, 조습성 및 휘발성 유기화합물의 흡착 분해 효능이 우수한 도료 조성물을 제공하기 위한 것이다.Accordingly, the present invention is to provide a coating composition excellent in antibacterial activity, but excellent in hygroscopicity and adsorptive decomposition efficacy of volatile organic compounds.
본 발명은 The present invention
하기 화학식 1의 화합물, 하기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 하기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물;At least one compound selected from the group consisting of a compound of Formula 1, a polymer compound comprising a compound of Formula 1 as a repeating unit, and a polyol compound having a compound of Formula 1;
실리콘(Si)과 티타늄(Ti)의 몰비가 7:3 내지 9:1인 실리카-티타니아 복합화합물; 및A silica-titania composite compound having a molar ratio of silicon (Si) and titanium (Ti) 7: 3 to 9: 1; And
바인더 수지Binder resin
를 포함하는 도료 조성물을 제공한다:It provides a coating composition comprising:
[화학식 1][Formula 1]
상기 화학식 1에서, In Formula 1,
R1은 10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실, 2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일, 2-히드록시-3-(4-노닐페녹시)프로필, 3-도데카플루오로-2-히드록시-4-옥사운데실, 2-히드록시-3-(메톡시)페녹시프로필, 2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필, 1-옥소-2-프로펜일, 또는 2-메틸-1-옥소-2-프로펜일 이고; R 1 is 10,11-epoxy-2,6-dihydroxy-4,8-dioxoundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2- Hydroxy-3- (4-nonylphenoxy) propyl, 3-dodecafluoro-2-hydroxy-4-oxoundecyl, 2-hydroxy-3- (methoxy) phenoxypropyl, 2-hydroxy Oxy-3- (toluene-4-sulfonyloxy) -propyl, 1-oxo-2-propenyl, or 2-methyl-1-oxo-2-propenyl;
R2 및 R3는 각각 독립적으로 수소기 또는 메틸기이고;R 2 and R 3 are each independently hydrogen or methyl;
R4 및 R5는 각각 독립적으로 수소기 또는 플루오르기이며;R 4 and R 5 are each independently hydrogen or fluorine;
R6는 수소기, 에틸기, 씨클로프로필기 또는 2,4-디플루오르페닐기이고;R 6 is a hydrogen group, an ethyl group, a cyclopropyl group or a 2,4-difluorophenyl group;
R7은 수소기, 메틸기 또는 아미노기이며;R 7 is a hydrogen group, a methyl group or an amino group;
R8, R9 및 R10은 각각 독립적으로 탄소 또는 질소이다.R 8 , R 9 and R 10 are each independently carbon or nitrogen.
본 발명에 따른 상기 도료 조성물은The coating composition according to the present invention
상기 바인더 수지 100 중량부에 대하여;100 parts by weight of the binder resin;
상기 화학식 1의 화합물, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 상기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물 0.1 내지 20 중량부;0.1 to 20 parts by weight of at least one compound selected from the group consisting of a compound of Formula 1, a polymer compound comprising a compound of Formula 1 as a repeating unit, and a polyol compound to which the compound of Formula 1 is bonded;
상기 실리카-티타니아 복합화합물 0.1 내지 20 중량부0.1 to 20 parts by weight of the silica-titania composite compound
를 포함할 수 있다.It may include.
여기서, 상기 실리카-티타니아 복합화합물은 실리콘(Si)과 티타늄(Ti)의 몰비가 7.5:2.5 내지 8.5:1.5인 것이 보다 바람직하다.Here, the silica-titania composite compound is more preferably a molar ratio of silicon (Si) and titanium (Ti) is 7.5: 2.5 to 8.5: 1.5.
한편, 상기 화학식 1의 화합물은 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실)-3-메틸-1-피페라진일]-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-{4-[2-히드록시-3-(4-노닐페녹시)프로필]-1-피페라진일}-5-옥소피리도[2,3-d]피리미딘-6-카복실산, 시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3,5-디메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-(2,4-디플루오로페닐)-6-플루오로-1,4-디히드로-7-[4-(2-히드록시-5-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-사이클로프로필-6-플루오로-7-[4-(3-도데카플루오로-2-히드록시-4-옥사운데실)-3-메틸-1-피페라진일]-1,4-디히드로-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플로로-1,4-디히드로-7-{4-[2-히드록시-3-(메톡시)페녹시프로필}-3-메틸-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-{4-[2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필]-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피퍼라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-5-옥소--피리도[2,3-d]피리미딘-6-카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 및 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(2-메틸-1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산으로 이루어진 군에서 선택되는 1종 이상의 화합물일 수 있다.On the other hand, the compound of Formula 1 is 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (10,11-epoxy-2,6-dihydroxy-4,8-di Oxoundecyl) -3-methyl-1-piperazinyl] -5-methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 8-ethyl -5,8-dihydro-2- {4- [2-hydroxy-3- (4-nonylphenoxy) propyl] -1-piperazinyl} -5-oxopyrido [2,3-d] Pyrimidine-6-carboxylic acid, cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4- Oxa-5-oxo-6-heptenyl) -3,5-dimethyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1- (2,4-difluorophenyl) -6-fluoro Rho-1,4-dihydro-7- [4- (2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4 Oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-7- [4- (3-degree Carfluoro-2-hydroxy-4-oxoundecyl) -3-methyl-1-piperazinyl] -1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl -6,8-difluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (methoxy) phenoxypropyl} -3-methyl-1-piperazinyl} -4 Oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (toluene-4-sulfonyloxy) -propyl]- 1-piperazinyl} -4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4- Oxa-5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- [4- ( 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 8-ethyl-5,8-dihydro- 2- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -5-oxo-pyrido [2,3-d] Pyrimidine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (1-oxo-2-propene ) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, and 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-methyl-1-oxo- 2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid may be one or more compounds selected from the group consisting of.
또한, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 2로 표시되는 것일 수 있다:In addition, the polymer compound including the compound of Formula 1 as a repeating unit may have a weight average molecular weight of 10,000 to 1,000,000 and is represented by the following Formula 2:
[화학식 2][Formula 2]
상기 화학식 2에서, In Formula 2,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고,R 1 to R 10 are the same as defined in Formula 1,
n은 분자량을 만족하게 하는 양의 정수이다.n is a positive integer satisfying the molecular weight.
또한, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 3으로 표시되는 랜덤 공중합체 또는 블록 공중합체인 것일 수 있다:In addition, the polymer compound including the compound of Formula 1 as a repeating unit may have a weight average molecular weight of 10,000 to 1,000,000 and a random copolymer or a block copolymer represented by Formula 3 below:
[화학식 3](3)
상기 화학식 3에서,In Formula 3,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고,R 1 to R 10 are the same as defined in Formula 1,
Y는 주쇄가 비닐알코올, 아크릴로니트릴, 부타디엔, 아크릴릭산, 스티렌, 아크릴이미드, 메틸메타아크릴산, 메타크릴산, 비닐클로라이드, 비닐플로라이드 또는 비닐아세테이트아크릴산인 반복단위이며,Y is a repeating unit whose main chain is vinyl alcohol, acrylonitrile, butadiene, acrylic acid, styrene, acrylimide, methylmethacrylic acid, methacrylic acid, vinyl chloride, vinyl fluoride or vinyl acetate acrylic acid,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.n and m are positive integers satisfying the molecular weight.
또한, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 4로 표시되는 랜덤 공중합체 또는 블록 공중합체일 수 있다:In addition, the polymer compound including the compound of Formula 1 as a repeating unit may have a weight average molecular weight of 10,000 to 1,000,000 and a random copolymer or a block copolymer represented by Formula 4 below:
[화학식 4][Formula 4]
상기 화학식 4에서,In Chemical Formula 4,
X는 하기 화학식 a로 표시되고,X is represented by the following formula a,
[화학식 a](A)
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같으며,R 1 to R 10 are the same as defined in Formula 1,
R11 및 R12는 각각 독립적으로 수소기 또는 메틸기이고,R 11 and R 12 are each independently a hydrogen group or a methyl group,
R13은 에스테르, 카보닐, 아미드, 아민, 시클로알킬, 에테르, 히드록시, 카르복실산, 질소(N) 또는 산소(O)를 함유하는 탄소수 2~10의 헤테로 고리, 설포닐, 실란, 락톤 및 알데히드로 이루어진 군에서 선택되는 1종 이상의 치환기를 포함하는 탄소수 1~18의 알킬기이며,R 13 is a heterocyclic ring having 2 to 10 carbon atoms, sulfonyl, silane, lactone containing ester, carbonyl, amide, amine, cycloalkyl, ether, hydroxy, carboxylic acid, nitrogen (N) or oxygen (O) And an alkyl group having 1 to 18 carbon atoms containing at least one substituent selected from the group consisting of aldehyde,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.n and m are positive integers satisfying the molecular weight.
또한, 상기 화학식 1의 화합물이 결합된 폴리올 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 5, 화학식 6, 화학식 7 또는 화학식 8로 표시되는 것일 수 있다:In addition, the polyol compound to which the compound of Formula 1 is bonded may have a weight average molecular weight of 10,000 to 1,000,000 and is represented by the following Formula 5, Formula 6, Formula 7 or Formula 8:
[화학식 5][Chemical Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
상기 화학식 5 내지 화학식 8에서,In Chemical Formulas 5 to 8,
Z는 하기 화학식 b로 표시되고,Z is represented by the following formula b,
[화학식 b][Formula b]
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같다.R 1 to R 10 are the same as defined in Chemical Formula 1.
또한, 상기 바인더 수지는 에폭시계 수지, 우레탄계 수지, 아크릴계 수지, 알키드계 수지, 우레아멜라민계 수지, 및 금속실리케이트계 수지로 이루어진 군에서 선택되는 1종 이상인 것일 수 있다.In addition, the binder resin may be one or more selected from the group consisting of an epoxy resin, a urethane resin, an acrylic resin, an alkyd resin, a urea melamine resin, and a metal silicate resin.
본 발명에 따른 도료 조성물은 항균 활성, 내열성, 조습성 및 휘발성 유기화합물의 흡착 분해 효능이 우수하여, 새집 증후군을 예방하는 등 상기 효과가 요구되는 다양한 분야에 유용하게 적용할 수 있다.The coating composition according to the present invention is excellent in antimicrobial activity, heat resistance, humidity control and adsorptive decomposition efficacy of volatile organic compounds, and can be usefully applied to various fields requiring the above effects such as preventing sick house syndrome.
이하, 본 발명의 구현예에 따른 도료 조성물에 대하여 설명하기로 한다.Hereinafter, the coating composition according to the embodiment of the present invention will be described.
그에 앞서, 본 명세서 전체에서 명시적인 언급이 없는 한, '실리카-티타니아 복합화합물'이라 실리카(SiO2) 및 티타니아(TiO2)의 단순 혼합물이 아니라, 6 배위 화합물을 형성하는 Ti4 + 양이온이 4 배위 화합물을 형성하는 Si 골격에 복합화 과정을 통해 치환 삽입되어 -Si-O-Ti- 의 링케이지(linkage)가 형성된 화합물로 정의한다.Prior to that, explicit mention this one, not throughout the present specification the "silica titania, complex compounds, as silica (SiO 2) and titania Ti 4 + cations, not a simple mixture of (TiO 2), form a six coordination compound It is defined as a compound in which a linkage of -Si-O-Ti- is formed by substitution insertion into a Si skeleton forming a 4-coordination compound through a complexing process.
한편, 본 발명자들은 도료 조성물에 대한 연구를 거듭하는 과정에서, 바인더 수지에 본 발명에 따른 항균성 화합물과 함께, 실리콘(Si)과 티타늄(Ti)이 특정 몰비로 복합화된 복합화합물을 혼합할 경우, 항균 활성뿐만 아니라, 조습성 및 휘발성 유기화합물의 흡착 분해 효능이 우수함을 확인하여 본 발명을 완성하였다.On the other hand, the present inventors, in the course of repeating the study on the coating composition, when mixing the composite compound of the silicon (Si) and titanium (Ti) complex in a specific molar ratio with the antimicrobial compound according to the present invention to the binder resin, In addition to the antimicrobial activity, it was confirmed that the hygroscopicity and the adsorptive decomposition efficacy of the volatile organic compounds was excellent, the present invention was completed.
이와 같은 본 발명은, 일 구현예에 따라,Such the present invention, according to one embodiment,
하기 화학식 1의 화합물, 하기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 하기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물;At least one compound selected from the group consisting of a compound of Formula 1, a polymer compound comprising a compound of Formula 1 as a repeating unit, and a polyol compound having a compound of Formula 1;
실리콘(Si)과 티타늄(Ti)의 몰비가 7:3 내지 9:1인 실리카-티타니아 복합화합물; 및A silica-titania composite compound having a molar ratio of silicon (Si) and titanium (Ti) 7: 3 to 9: 1; And
바인더 수지Binder resin
를 포함하는 도료 조성물을 제공한다:It provides a coating composition comprising:
[화학식 1][Formula 1]
상기 화학식 1에서, In Formula 1,
R1은 10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실, 2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일, 2-히드록시-3-(4-노닐페녹시)프로필, 3-도데카플루오로-2-히드록시-4-옥사운데실, 2-히드록시-3-(메톡시)페녹시프로필, 2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필, 1-옥소-2-프로펜일, 또는 2-메틸-1-옥소-2-프로펜일 이고; R 1 is 10,11-epoxy-2,6-dihydroxy-4,8-dioxoundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2- Hydroxy-3- (4-nonylphenoxy) propyl, 3-dodecafluoro-2-hydroxy-4-oxoundecyl, 2-hydroxy-3- (methoxy) phenoxypropyl, 2-hydroxy Oxy-3- (toluene-4-sulfonyloxy) -propyl, 1-oxo-2-propenyl, or 2-methyl-1-oxo-2-propenyl;
R2 및 R3는 각각 독립적으로 수소기 또는 메틸기이고;R 2 and R 3 are each independently hydrogen or methyl;
R4 및 R5는 각각 독립적으로 수소기 또는 플루오르기이며;R 4 and R 5 are each independently hydrogen or fluorine;
R6는 수소기, 에틸기, 씨클로프로필기 또는 2,4-디플루오르페닐기이고;R 6 is a hydrogen group, an ethyl group, a cyclopropyl group or a 2,4-difluorophenyl group;
R7은 수소기, 메틸기 또는 아미노기이며;R 7 is a hydrogen group, a methyl group or an amino group;
R8, R9 및 R10은 각각 독립적으로 탄소 또는 질소이다.R 8 , R 9 and R 10 are each independently carbon or nitrogen.
본 발명에 따른 도료 조성물은 외부로부터의 오염에 의해 발생하는 세균, 곰팡이 등을 억제할 수 있을 뿐만 아니라, 실내의 습도에 따라 자율적으로 흡습 또는 방습하여 실내 습도를 조절할 수 있으며, 건축 내장재 등에서 발생되는 휘발성 유기화합물(VOCs) 등을 흡착 및 분해할 수 있다.The coating composition according to the present invention can not only suppress bacteria, molds, and the like caused by contamination from the outside, but also can control the humidity in the room by controlling moisture or autonomously according to the humidity of the room. Volatile organic compounds (VOCs) and the like can be adsorbed and decomposed.
이하, 본 발명의 도료 조성물에 포함되는 각 성분에 대하여 설명한다.Hereinafter, each component contained in the coating composition of this invention is demonstrated.
먼저, 상기 바인더 수지는 도료 조성물에 바름성을 부여하고, 조성물에 포함되는 고형분을 안정적으로 부착시키는 역할을 하는 성분이다.First, the binder resin is a component that gives a coating property to the coating composition, and serves to stably attach the solid content included in the composition.
본 발명에 따르면, 상기 바인더 수지는 에폭시계 수지, 우레탄계 수지, 아크릴계 수지, 알키드계 수지, 우레아멜라민계 수지, 및 금속실리케이트계 수지로 이루어진 군에서 선택되는 1종 이상이 바람직하다.According to the present invention, the binder resin is preferably one or more selected from the group consisting of epoxy resins, urethane resins, acrylic resins, alkyd resins, urea melamine resins, and metal silicate resins.
이때, 상기 바인더 수지는 전술한 성분들과의 관계를 고려하여, 최소한의 접착력을 부여하여 박리현상을 방지할 수 있으면서도, 전술한 성분들에 의한 효과가 충분히 발현될 수 있도록 하는 함량 범위 내에서 조성물에 포함될 수 있다.
In this case, the binder resin may be prevented from the peeling phenomenon by giving a minimum adhesive force in consideration of the relationship with the above-described components, while the composition within the content range to sufficiently express the effect by the above-described components Can be included.
한편, 본 발명에 따른 도료 조성물은 상기 실리카-티타니아 복합화합물을 포함한다. 상기 실리카-티타니아 복합화합물은 앞서 정의한 바와 같이, 실리카(SiO2) 및 티타니아(TiO2)의 단순 혼합물이 아니라, 6 배위 화합물을 형성하는 Ti4 + 양이온이 4 배위 화합물을 형성하는 Si 골격에 복합화 과정을 통해 치환 삽입되어 -Si-O-Ti- 의 링케이지(linkage)가 형성된 화합물이다.On the other hand, the coating composition according to the present invention comprises the silica-titania composite compound. The silica-like titania, complex compounds are as defined above, silica (SiO 2) and titania composite in the Si skeleton, not a simple mixture of (TiO 2), it is Ti 4 + cations to form the 6 coordination compound to form a 4-coordination compound Substituted through the process to form a linkage (linkage) of -Si-O-Ti-.
상기 실리카-티타니아 복합화합물은 Ti 양이온의 치환으로 인해 결합 거리가 달라지게 되어 음전하 과잉 현상이 일어나고, 이때 전기적 중성을 유지하기 위해 프로톤을 끌어들이는 브렌스테드 산점이 발현된다. 그에 따라 실리카(SiO2) 및 티타니아(TiO2)의 단순 혼합물에 비하여, 휘발성 유기화합물 등을 보다 효율적으로 흡착 및 분해할 수 있게 된다.In the silica-titania composite compound, the bonding distance is changed due to the substitution of the Ti cation, so that a negative charge excess occurs, and at this time, the Brentstead acid point that draws protons to maintain electrical neutrality is expressed. As a result, compared to a simple mixture of silica (SiO 2 ) and titania (TiO 2 ), volatile organic compounds and the like can be more efficiently adsorbed and decomposed.
뿐만 아니라, 상기 실리카-티타니아 복합화합물은 표면에 무수한 미세기공이 존재함에 따라 우수한 자율 조습성을 발현할 수 있다. 즉, 상기 실리카-티타니아 복합화합물은 주변의 습도가 상대적으로 높아지면 기공 내에 수증기를 응축시키고, 습도가 상대적으로 낮아지면 응축된 수분이 증발되어 적정 습도를 유지할 수 있게 된다.In addition, the silica-titania composite compound may express excellent self-humidity as there are a myriad of micropores on the surface. That is, the silica-titania composite compound condenses water vapor in the pores when the surrounding humidity is relatively high, and when the humidity is relatively low, the condensed water is evaporated to maintain an appropriate humidity.
또한, 상기 실리카-티타니아 복합화합물은 미세기공을 통해 실내의 건축 내장재에서 방출되는 휘발성 유기화합물(VOCs) 등의 유해 화합물을 흡착할 수 있다. 그리고, 태양광 등의 에너지선에 의해 실리카-티타니아 복합화합물이 활성화되어 흡착된 유해 화합물을 분해할 수 있는 효과를 나타낸다.In addition, the silica-titania composite compound may adsorb harmful compounds, such as volatile organic compounds (VOCs), which are released from interior building interior materials through micropores. In addition, the silica-titania composite compound is activated by energy rays such as sunlight to decompose the adsorbed harmful compounds.
이때, 본 발명에 따르면, 상기 실리카-티타니아 복합화합물은 실리콘(Si)과 티타늄(Ti)의 몰비가 7:3 내지 9:1로 복합화된 것이 바람직하고; 실리콘(Si)과 티타늄(Ti)의 몰비가 7.5:2.5 내지 8.5:1.5로 복합화된 것이 보다 바람직하다. 즉, 상기 효과를 발현할 수 있는 미세기공의 크기, 용적(공극율) 및 유해 화합물의 분해 효능 등을 감안하여, 상기 실리카-티타니아 복합화합물은 실리콘과 티타늄의 몰비가 상기 범위로 복합화된 것이 바람직하다.At this time, according to the present invention, the silica-titania composite compound preferably comprises a molar ratio of silicon (Si) and titanium (Ti) 7: 3 to 9: 1; More preferably, the molar ratio of silicon (Si) and titanium (Ti) is compounded at 7.5: 2.5 to 8.5: 1.5. That is, in view of the size, volume (porosity) of the micropores capable of expressing the effect, and the decomposition efficiency of harmful compounds, the silica-titania composite compound is preferably a compound of the molar ratio of silicon and titanium in the above range. .
또한, 상기 실리카-티타니아 복합화합물은 실리콘과 티타늄의 몰비가 상기 범위로 복합화된 것이라면 그 제조방법을 특별히 제한하지 않는다. 다만, 본 발명의 일 구현예에 따르면, TiCl4를 부분 가수분해시켜 TiOCl2 용액을 제조한 후, 여기에 소듐실리케이드 수용액을 전술한 몰비가 되도록 혼합하는 단계; 상기 혼합 용액을 pH 7로 조절한 후, 70 내지 100 ℃의 온도에서 1 내지 4 시간 동안 반응시키는 단계; 및 상기 반응 생성물을 여과 및 건조한 후, 300 내지 1100 ℃에서 소성하는 단계를 포함하는 방법으로 수행하는 것이 바람직하다.In addition, the silica-titania composite compound is not particularly limited as long as the molar ratio of silicon and titanium is compounded in the above range. However, according to one embodiment of the present invention, after preparing TiOCl 2 solution by partially hydrolyzing TiCl 4 , mixing the aqueous solution of sodium silicate to the above molar ratio; Adjusting the mixed solution to pH 7 and reacting at a temperature of 70 to 100 ° C. for 1 to 4 hours; And after the reaction product is filtered and dried, it is preferably carried out by a method comprising the step of firing at 300 to 1100 ℃.
이와 같은, 상기 실리카-티타니아 복합화합물은 상기 바인더 수지 100 중량부에 대하여, 0.1 내지 20 중량부, 바람직하게는 0.5 내지 15 중량부, 보다 바람직하게는 1 내지 10 중량부로 포함될 수 있다.As such, the silica-titania composite compound may be included in an amount of 0.1 to 20 parts by weight, preferably 0.5 to 15 parts by weight, and more preferably 1 to 10 parts by weight, based on 100 parts by weight of the binder resin.
즉, 실리카-티타니아 복합화합물에 의한 최소한의 효과 발현을 위하여 상기 실리카-티타니아 복합화합물은 상기 바인더 수지 100 중량부에 대하여 0.1 중량부 이상 포함되는 것이 바람직하다. 또한, 상기 실리카-티타니아 복합화합물을 과량으로 첨가할 경우 도료 조성물의 바름성이 저하되고 표면 갈라짐이 발생할 수 있고, 입자들의 응집으로 인해 오히려 조습 및 VOCs 흡착 분해 효율이 떨어질수 있는데, 이를 방지하기 위하여, 상기 바인더 수지 100 중량부에 대하여 20 중량부 이하로 포함되는 것이 바람직하다.
That is, the silica-titania composite compound is preferably included 0.1 parts by weight or more based on 100 parts by weight of the binder resin in order to express the minimum effect by the silica-titania composite compound. In addition, when the silica-titania composite compound is added in an excessive amount, the paintability of the coating composition may be degraded and surface cracking may occur. Due to the aggregation of particles, humidity and VOCs adsorption decomposition efficiency may be deteriorated. It is preferably included in 20 parts by weight or less based on 100 parts by weight of the binder resin.
한편, 본 발명에 따른 도료 조성물은 하기 화학식 1의 화합물, 하기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 하기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물을 포함한다:On the other hand, the coating composition according to the present invention is at least one compound selected from the group consisting of a compound of formula 1, a polymer compound comprising a compound of formula 1 as a repeating unit, and a polyol compound to which the compound of formula 1 is bonded Includes:
[화학식 1][Formula 1]
상기 화학식 1에서, In Formula 1,
R1은 10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실, 2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일, 2-히드록시-3-(4-노닐페녹시)프로필, 3-도데카플루오로-2-히드록시-4-옥사운데실, 2-히드록시-3-(메톡시)페녹시프로필, 2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필, 1-옥소-2-프로펜일, 또는 2-메틸-1-옥소-2-프로펜일 이고; R 1 is 10,11-epoxy-2,6-dihydroxy-4,8-dioxoundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2- Hydroxy-3- (4-nonylphenoxy) propyl, 3-dodecafluoro-2-hydroxy-4-oxoundecyl, 2-hydroxy-3- (methoxy) phenoxypropyl, 2-hydroxy Oxy-3- (toluene-4-sulfonyloxy) -propyl, 1-oxo-2-propenyl, or 2-methyl-1-oxo-2-propenyl;
R2 및 R3는 각각 독립적으로 수소기 또는 메틸기이고;R 2 and R 3 are each independently hydrogen or methyl;
R4 및 R5는 각각 독립적으로 수소기 또는 플루오르기이며;R 4 and R 5 are each independently hydrogen or fluorine;
R6는 수소기, 에틸기, 씨클로프로필기 또는 2,4-디플루오르페닐기이고;R 6 is a hydrogen group, an ethyl group, a cyclopropyl group or a 2,4-difluorophenyl group;
R7은 수소기, 메틸기 또는 아미노기이며;R 7 is a hydrogen group, a methyl group or an amino group;
R8, R9 및 R10은 각각 독립적으로 탄소 또는 질소이다.R 8 , R 9 and R 10 are each independently carbon or nitrogen.
상기 화합물은 조성물에 항균 활성을 부여할 수 있는 성분으로서, 바인더 수지와 혼합되더라도 지속적인 항균 활성을 유지할 수 있을 뿐만 아니라. 내열성이 우수하고, 외부로 용출되지 않으며, 조성물의 물성에 영향을 미치지 않는 장점이 있다.The compound is a component capable of imparting antimicrobial activity to the composition, even when mixed with a binder resin, it can not only maintain a continuous antimicrobial activity. Excellent heat resistance, does not elute to the outside, there is an advantage that does not affect the physical properties of the composition.
특히, 상기 화합물을 전술한 실리카-티타니아 복합화합물과 함께 사용함으로써, 상기 화학식 1의 화합물을 기초로 한 화합물이 실리카-티타니아 복합화합물의 표면에 결합하게 된다.In particular, by using the compound in combination with the above-described silica-titania composite compound, the compound based on the compound of Formula 1 is bonded to the surface of the silica-titania composite compound.
여기서, 전술한 실리카-티타니아 복합화합물은 자체적으로도 항균 효과를 나타낼 수 있는데, 상기 실리카-티타니아 복합화합물이 항균 활성을 나타내기 위해서는 UV 등 빛의 존재가 필수적으로 요구된다.Here, the above-described silica-titania composite compound may exhibit an antibacterial effect on its own, and in order for the silica-titania composite compound to exhibit antibacterial activity, the presence of light such as UV is essential.
이러한 관점에서, 본 발명에 따른 도료 조성물은 상기 실리카-티타니아 복합화합물의 표면에 상기 화학식 1의 화합물을 기초로 한 화합물이 결합됨에 따라, UV 등 빛의 존재 여부와 관계없이 항균 활성을 나타낼 수 있는 시너지 효과를 얻을 수 있다. 예를 들면, 빛이 존재하는 환경에서는, 상기 실리카-티타니아 복합화합물과 상기 화학식 1의 화합물을 기초로 한 화합물에 의해 항균 활성 및 조습성이 원활하게 발현될 수 있다. 뿐만 아니라, 빛이 존재하지 않는 환경에서도, 상기 실리카-티타니아 복합화합물의 기공에 Van der Waals 인력에 의해 대기 중의 부유균이 흡착되고, 상기 화학식 1의 화합물을 기초로 한 화합물에 의해 항균 활성을 유지할 수 있게 된다.In this regard, the coating composition according to the present invention, as the compound based on the compound of Formula 1 is bonded to the surface of the silica-titania composite compound, can exhibit antimicrobial activity regardless of the presence of light such as UV Synergy can be obtained. For example, in an environment where light is present, antimicrobial activity and humidity control can be smoothly expressed by the silica-titania composite compound and the compound based on the compound of Formula 1. In addition, even in the absence of light, airborne bacteria are adsorbed to the pores of the silica-titania composite compound by Van der Waals attraction, and the antibacterial activity is maintained by the compound based on the compound of Formula 1. It becomes possible.
또한, 이전에는 대기중에 표류 중인 부유균이 도료 조성물과 직접 닿아야만 항균 활성 효과를 얻을 수 있었던 것에 비하여, 본 발명에 따른 도료 조성물은 상기 실리카-티타니아 복합화합물 및 상기 화학식 1의 화합물을 기초로 한 화합물을 동시에 포함함에 따라 부유균을 자율적으로 흡착할 수 있고, 보다 우수한 항균 활성을 나타낼 수 있다.
In addition, in the past, the floating bacteria in the air had to be in direct contact with the coating composition to obtain the antimicrobial activity, whereas the coating composition according to the present invention is based on the silica-titania composite compound and the compound of Formula 1 By including the compound at the same time can be adsorbed suspended bacteria autonomously, it can exhibit a better antimicrobial activity.
본 발명의 조성물에 포함되는 상기 성분은 상기 화학식 1의 화합물을 기초로 한 화합물들로서; 바람직하게는 상기 화학식 1의 화합물, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 상기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물일 수 있다. 여기서, 상기 화합물들에 대한 내용은 대한민국 등록특허 제0536551호에 기재된 모든 내용을 포함한다.
The components included in the composition of the present invention are compounds based on the compound of Formula 1; Preferably, at least one compound selected from the group consisting of a compound of Formula 1, a polymer compound including a compound of Formula 1 as a repeating unit, and a polyol compound to which the compound of Formula 1 is bonded. Herein, the contents of the compounds include all the contents described in Korean Patent Registration No. 0536551.
상기 화합물들 중에서, 상기 화학식 1의 화합물은 하기 반응식 1의 방법을 통해 제조될 수 있다:Among the compounds, the compound of Formula 1 may be prepared by the method of Scheme 1 below:
[반응식 1][Reaction Scheme 1]
상기 반응식 1에서,In the above Reaction Scheme 1,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고, A는 할로겐기이다.R 1 to R 10 are the same as defined in Chemical Formula 1, and A is a halogen group.
즉, 상기 화학식 1의 화합물은 상기 반응식 1과 같이, 화합물 II와 화합물 III-(a)를 반응시켜 제조될 수 있는데, 이때 상기 화합물 II에 대한 화합물 III-(a)의 당량비는 1:0.8 내지 1:1.5인 것이 바람직하고, 반응 온도는 -40 ℃ 내지 130 ℃인 것이 바람직하다.That is, the compound of Formula 1 may be prepared by reacting Compound II with Compound III- (a), as in Scheme 1, wherein the equivalent ratio of Compound III- (a) to Compound II is 1: 0.8 to It is preferable that it is 1: 1.5, and it is preferable that reaction temperature is -40 degreeC-130 degreeC.
또한, 반응 중에 발생되는 산(예를 들면 염화수소)를 제거하기 위하여 스카벤저(scavenger)를 더욱 첨가할 수 있다. 상기 스카벤저로는 테트라메틸구아니딘, 디에틸아민, 피롤리딘, 트리메틸아민, 트리에틸아민, 피리딘 또는 피페리딘, 칼슘히드록사이드, 소디움하이드록사이드, 칼슘카보네이트, 칼륨카보네이트 등을 단독 또는 2종 이상 사용할 수 있으며, 화합물 II에 대하여 스카벤저를 1:1 내지 1:3 당량비로 사용하는 것이 바람직하다.In addition, a scavenger may be further added to remove the acid (eg hydrogen chloride) generated during the reaction. Examples of the scavenger include tetramethylguanidine, diethylamine, pyrrolidine, trimethylamine, triethylamine, pyridine or piperidine, calcium hydroxide, sodium hydroxide, calcium carbonate, potassium carbonate, and the like. It is possible to use more than one species, and it is preferable to use a skavenger in a ratio of 1: 1 to 1: 3 equivalents relative to compound II.
또한, 상기 화학식 1의 화합물은 하기 반응식 2의 방법을 통해 제조될 수 있다:In addition, the compound of Formula 1 may be prepared by the method of Scheme 2:
[반응식 2]Scheme 2
상기 반응식 2에서,In the above Reaction Scheme 2,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고, R 1 to R 10 are the same as defined in Formula 1,
Ra는 술포닐, 할로겐원소, 니트로, 히드록시, 티오닐(-SH), 아민(1차, 2차, 3차), 아마이드, 이민, 카바메이트, 옥심, 카보닐, 카복시, 에폭시, 아크릴, 에스테르, 페닐, 비닐 및 니트릴로 이루어진 군에서 선택되는 1종 이상의 작용기를 포함하는 C1?C20의 포화 또는 불포화 탄화수소이다.R a is sulfonyl, halogen, nitro, hydroxy, thionyl (-SH), amine (primary, secondary, tertiary), amide, imine, carbamate, oxime, carbonyl, carboxy, epoxy, acryl , C 1 -C 20 saturated or unsaturated hydrocarbons comprising at least one functional group selected from the group consisting of esters, phenyl, vinyl and nitrile.
즉, 상기 화학식 1의 화합물은 상기 반응식 1과 같이, 화합물 II와 화합물 III-(b)의 에폭시 개환 반응을 통해서도 제조될 수 있으며, 이때 상기 화합물 II에 대한 화합물 III-(b)의 당량비는 1:0.8 내지 1:4인 것이 바람직하고, 반응 온도는 35 ℃ 내지 150 ℃인 것이 바람직하다.That is, the compound of Formula 1 may also be prepared through the epoxy ring-opening reaction of Compound II and Compound III- (b) as in Scheme 1, wherein the equivalent ratio of Compound III- (b) to Compound II is 1 It is preferable that it is: 0.8-1: 4, and it is preferable that reaction temperature is 35 degreeC-150 degreeC.
상기 반응식 1 및 반응식 2는 모두 유기용매의 존재 하에서 수행될 수 있다. 상기 유기용매로는 N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 디메틸설폭사이드, 자일렌, 테트라하이드로퓨란, 벤젠, 톨루엔, 아세토니트릴, 디클로로메탄, 에틸아세테이트, 부틸아세테이트, 1,4-다이옥산 및 클로로포름으로 이루어진 군에서 선택되는 1종 이상을 사용할 수 있다.Both Scheme 1 and Scheme 2 can be carried out in the presence of an organic solvent. The organic solvent may be N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide, xylene, tetrahydrofuran, benzene, toluene, acetonitrile, dichloromethane, ethyl acetate, butyl acetate, 1, One or more selected from the group consisting of 4-dioxane and chloroform can be used.
또한, 상기 반응식 1 및 반응식 2에서, 상기 화합물 II는 1-사이클로프로필-6-플로로-1,4-디히드로-5-메틸-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플로로-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-(1-피페라진일)-5-옥소-피리도[2,3-d]피리미딘-6-카복실산, (시스)-5-아미노-1-싸이클로프로필-6,8-디플로로-1,4-디히드로-7-(3,5-디메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산, 1-(2,4-디플로로페닐)-6-플로로-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산, 1-싸이클로프로필-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 또는 이들의 염일 수 있다.In addition, in Scheme 1 and Scheme 2, compound II is 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7- (3-methyl-1-piperazinyl) -4 Oxo-3-quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid, 8-ethyl-5,8-dihydro-2- (1-piperazinyl) -5-oxo-pyrido [2,3-d] pyrimidine-6-carboxylic acid, (cis) -5-amino-1 -Cyclopropyl-6,8-difluoro-1,4-dihydro-7- (3,5-dimethyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid, 1- (2,4 -Difluorophenyl) -6-fluoro-1,4-dihydro-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro -1,4-dihydro-7- (1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7- (1-pipe Razinyl) -4-oxo-3-quinolinecarboxylic acid or salts thereof.
또한, 상기 화합물 III-(a)는 아크릴로일클로라이드, 메타크릴로일클로라이드, 비닐클로라이드 또는 비닐벤질클로라이드를 포함하는 할로겐 화합물일 수 있다.In addition, the compound III- (a) may be a halogen compound including acryloyl chloride, methacryloyl chloride, vinyl chloride or vinyl benzyl chloride.
또한, 상기 화합물 III-(b)는 글리세롤디글리시딜에테르, 2-메틸아크릴릭엑시드옥시라닐메틸에스테르, 글리시딜논닐페닐에테르, 글리시딜도데카플로로헵틸에테르, 글리시딜-4-메톡시페닐에테르, 2-메틸아크릴릭엑시드옥시라닐에스테르, 2,3-에폭시프로필메타아크릴레이트, 4-클로로페닐글리시딜에테르, 1-클로로-2,3-에폭시프로판, 글리시딜메타아크릴레이트, 글리시돌, 아크릭엑시드옥시라닐메틸에스테르, 2-아릴옥시메틸옥시란, 2-펜트-4-엔닐옥시란, 2-비닐옥시란, 헥사데카플로로노닐옥시메틸옥시란, 도데카플로로헵틸옥시메틸옥시란, 옥타플로로펜틸옥시메틸옥시란, 2-(4-노닐페녹시메틸)옥시란, 4-니트로벤조산옥시라닐메틸에스테르, 니트로벤젠솔포닉산옥시라닐메틸에스터, 톨루엔4-솔포닉산옥시라닐메틸에스테르, 트리틸옥시메틸옥시란, 1,3-비스옥시라닐메톡시프로판-2-올그리세롤프로폭시레이트트리글리시딜에스테르, 에피클로로 히드린 또는 글리시독시프로필트리메톡시실란일 수 있다.In addition, the compound III- (b) is glycerol diglycidyl ether, 2-methyl acrylic acid oxyranyl methyl ester, glycidyl nonyl phenyl ether, glycidyl dodecafluoroheptyl ether, glycidyl-4-meth Oxyphenyl ether, 2-methyl acrylic acid oxyranyl ester, 2,3-epoxypropyl methacrylate, 4-chlorophenyl glycidyl ether, 1-chloro-2,3-epoxypropane, glycidyl methacrylate, Glycidol, Aric acid oxyranyl methyl ester, 2-aryloxy methyl oxirane, 2-pent-4-enyl oxirane, 2-vinyl oxirane, hexadecaflorononyloxymethyl oxirane, dodecafluoroheptyl Oxymethyl oxirane, octafluoropentyloxymethyl oxirane, 2- (4-nonylphenoxymethyl) oxirane, 4-nitrobenzoic acid oxyranylmethyl ester, nitrobenzene solphonic acid oxyranyl methyl ester, toluene 4-sulfonic acid Oxiranylmethyl ester, trityloxymethyloxirane, 1, 3- ratio Oxiranyl -dihydroxy-20 2-ol may be a draw of three Rolf epoxy acrylate triglycidyl ester, epichlorohydrin or glycidoxypropyltrimethoxysilane.
이와 같은 상기 화학식 1의 화합물(화합물 I)은, 바람직하게는 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실)-3-메틸-1-피페라진일]-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-{4-[2-히드록시-3-(4-노닐페녹시)프로필]-1-피페라진일}-5-옥소피리도[2,3-d]피리미딘-6-카복실산, 시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3,5-디메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-(2,4-디플루오로페닐)-6-플루오로-1,4-디히드로-7-[4-(2-히드록시-5-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-사이클로프로필-6-플루오로-7-[4-(3-도데카플루오로-2-히드록시-4-옥사운데실)-3-메틸-1-피페라진일]-1,4-디히드로-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플로로-1,4-디히드로-7-{4-[2-히드록시-3-(메톡시)페녹시프로필}-3-메틸-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-{4-[2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필]-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피퍼라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-5-옥소--피리도[2,3-d]피리미딘-6-카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 및 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(2-메틸-1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산으로 이루어진 군에서 선택되는 1종 이상일 수 있다.Such a compound of formula 1 (compound I) is preferably 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (10,11-epoxy-2,6-di Hydroxy-4,8-dioxoundecyl) -3-methyl-1-piperazinyl] -5-methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1 , 4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo- 3-Quinolinecarboxylic acid, 8-ethyl-5,8-dihydro-2- {4- [2-hydroxy-3- (4-nonylphenoxy) propyl] -1-piperazinyl} -5-oxopyri Fig. [2,3-d] pyrimidine-6-carboxylic acid, cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydrate Roxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3,5-dimethyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1- (2,4-di Fluorophenyl) -6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl- 1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1-cycle Propyl-6-fluoro-7- [4- (3-dodecafluoro-2-hydroxy-4-oxoundecyl) -3-methyl-1-piperazinyl] -1,4-dihydro- 5-Methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (methoxy) phenoxy Cipropyl} -3-methyl-1-piperazinyl} -4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- {4- [2-hydroxy -3- (toluene-4-sulfonyloxy) -propyl] -1-piperazinyl} -4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7 -[4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6- Floro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo- 3-Quinolinecarboxylic acid, 8-ethyl-5,8-dihydro-2- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl ] -5-oxo-pyrido [2,3-d] pyrimidine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4- Hydro-7- [4- (1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, and 1-cyclopropyl-6-fluoro-1,4-di Hydro-7- [4- (2-methyl-1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid.
한편, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 상기 화학식 1의 화합물을 반복단위로 하는 단일 중합체(homo-polymer) 또는 공중합체(co-polymer)일 수 있다. 이때, 상기 고분자 화합물은 반응성 및 물성 등을 고려하여, 중량평균 분자량이 10,000 내지 1,000,000인 것이 바람직하다.Meanwhile, the polymer compound including the compound of Formula 1 as a repeating unit may be a homopolymer or a copolymer having the compound of Formula 1 as a repeating unit. In this case, the polymer compound has a weight average molecular weight of 10,000 to 1,000,000 in consideration of reactivity and physical properties.
여기서, 상기 화학식 1의 화합물의 단일 중합체는 하기 화학식 2로 표시되는 것일 수 있다:Here, the homopolymer of the compound of Formula 1 may be represented by the following Formula 2:
[화학식 2][Formula 2]
상기 화학식 2에서, R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고, n은 분자량을 만족하게 하는 양의 정수이다.In Formula 2, R 1 to R 10 are the same as defined in Formula 1, and n is a positive integer satisfying the molecular weight.
또한, 상기 화학식 1의 화합물을 반복단위로 포함하는 공중합체는 하기 화학식 3으로 표시되는 것일 수 있다:In addition, the copolymer comprising the compound of Formula 1 as a repeating unit may be represented by the following formula (3):
[화학식 3](3)
상기 화학식 3에서,In Formula 3,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고,R 1 to R 10 are the same as defined in Formula 1,
Y는 주쇄가 비닐알코올, 아크릴로니트릴, 부타디엔, 아크릴릭산, 스티렌, 아크릴이미드, 메틸메타아크릴산, 메타크릴산, 비닐클로라이드, 비닐플로라이드 또는 비닐아세테이트아크릴산인 반복단위이며,Y is a repeating unit whose main chain is vinyl alcohol, acrylonitrile, butadiene, acrylic acid, styrene, acrylimide, methylmethacrylic acid, methacrylic acid, vinyl chloride, vinyl fluoride or vinyl acetate acrylic acid,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.n and m are positive integers satisfying the molecular weight.
상기 화학식 3의 공중합체는 상기 화학식 1의 화합물과 Y 단량체를 1:1 내지 1:100의 당량비로 라디칼 공중합시켜 제조될 수 있는 것으로서, 본 발명이 속하는 기술분야에서 통상적인 개시제 및 반응 조건 하에서 제조될 수 있으므로, 그 제조방법을 특별히 제한하지 않는다. The copolymer of Chemical Formula 3 may be prepared by radical copolymerization of the compound of Chemical Formula 1 with the Y monomer in an equivalent ratio of 1: 1 to 1: 100, and is prepared under conventional initiator and reaction conditions in the art to which the present invention pertains. Since it may be, the manufacturing method is not particularly limited.
또한, 상기 공중합체는 랜덤 공중합체 또는 블록 공중합체일 수 있으며, 반응성 및 물성 등을 고려하여 중량평균 분자량이 10,000 내지 1,000,000인 것이 바람직하다.In addition, the copolymer may be a random copolymer or a block copolymer, it is preferable that the weight average molecular weight is 10,000 to 1,000,000 in consideration of reactivity and physical properties.
또한, 상기 화학식 1의 화합물을 반복단위로 포함하는 공중합체는 하기 화학식 4로 표시되는 아크릴계 공중합체일 수 있다:In addition, the copolymer including the compound of Formula 1 as a repeating unit may be an acrylic copolymer represented by Formula 4 below:
[화학식 4][Formula 4]
상기 화학식 4에서,In Chemical Formula 4,
X는 하기 화학식 a로 표시되고,X is represented by the following formula a,
[화학식 a](A)
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같으며, R 1 to R 10 are the same as defined in Formula 1,
R11 및 R12는 각각 독립적으로 수소기 또는 메틸기이고,R 11 and R 12 are each independently a hydrogen group or a methyl group,
R13은 에스테르, 카보닐, 아미드, 아민, 시클로알킬, 에테르, 히드록시, 카르복실산, 질소(N) 또는 산소(O)를 함유하는 탄소수 2~10의 헤테로 고리, 설포닐, 실란, 락톤 및 알데히드로 이루어진 군에서 선택되는 1종 이상의 치환기를 포함하는 탄소수 1~18의 알킬기이며,R 13 is a heterocyclic ring having 2 to 10 carbon atoms, sulfonyl, silane, lactone containing ester, carbonyl, amide, amine, cycloalkyl, ether, hydroxy, carboxylic acid, nitrogen (N) or oxygen (O) And an alkyl group having 1 to 18 carbon atoms containing at least one substituent selected from the group consisting of aldehyde,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.n and m are positive integers satisfying the molecular weight.
이때, 상기 화학식 4의 화합물은 하기 반응식 3의 방법을 통해 제조될 수 있다:In this case, the compound of Formula 4 may be prepared by the method of Scheme 3:
[반응식 3]Scheme 3
상기 반응식 3에서, X, R11, R12 및 R13은 상기 화학식 4에서 정의한 바와 같다.In Scheme 3, X, R 11 , R 12 and R 13 are the same as defined in Chemical Formula 4.
상기 반응식 3에서, 화학식 A의 화합물은 전술한 반응식 2에서의 화합물 II와 에폭사이드 화합물을 고리 열림 반응시켜 수득할 수 있으며, 상기 에폭사이드 화합물로는 글리시딜메타크릴레이트 등을 예로 들 수 있다.In Scheme 3, the compound of Formula A may be obtained by ring-opening reaction of Compound II and the epoxide compound in Scheme 2, and the epoxide compound may include glycidyl methacrylate and the like. .
또한, 상기 반응식 3에서, 화학식 B의 화합물은 주쇄가 아크릴산 또는 메타크릴산에 기인하는 탄화수소쇄(hydrocarbon chain)인 아크릴계 단량체일 수 있으며; 바람직하게는, 아크릴산, 아크릴산알킬에스테르, 메타크릴산 또는 메타크릴산알킬에스테르를 가지는 단량체일 수 있다. In addition, in Scheme 3, the compound of Formula B may be an acrylic monomer whose main chain is a hydrocarbon chain derived from acrylic acid or methacrylic acid; Preferably, it may be a monomer having acrylic acid, alkyl acrylate, methacrylic acid or methacrylic acid alkyl ester.
상기 아크릴산알킬에스테르 및 메타크릴산알킬에스테르는 C1?C18의 알킬을 포함하는 것이 보다 바람직하다. 이러한 아크릴산알킬에스테르의 예로는 아크릴산메틸, 아크릴산에틸, 아크릴산 n-프로필, 아크릴산이소프로필, 아크릴산시클로헥실, 아크릴산t-부틸시클로헥실, 아크릴산스테아릴 및 아크릴산라우릴이 있다. As for the said acrylic acid alkyl ester and methacrylic acid alkyl ester, it is more preferable that C1-C18 alkyl is included. Examples of such alkyl acrylates include methyl acrylate, ethyl acrylate, n-propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, t-butylcyclohexyl acrylate, stearyl acrylate and lauryl acrylate.
또한 상기 아크릴계 단량체는 반응성 작용기를 포함할 수 있으며, 작용기의 예로는 아미드기, 수산기, 에폭시기, 실란올기 또는 알데히드기가 있다. 보다 구체적으로, 반응성 작용기를 더욱 포함하는 아크릴계 단량체로는 아크릴아미드, 메타크릴아미드, N-메틸아크릴아미드, N-메틸올아크릴아미드, N-부톡시메틸아크릴아미드, N-메틸메타크릴아미드, N-부톡시메틸메타크릴아미드, 아크릴산히드록시에틸, 메타크릴산히드록시에틸, 아크릴산히드록시프로필, 메타크릴산히드록시프로필, 아크릴산글리시딜, 메타크릴산글리시딜, γ-트리메톡시실란메타크릴레이트, γ-트리에톡시실란메타크릴레이트, 아크롤레인, 카프로락톤 변성 히드록시아크릴레이트 또는 카프로락톤 변성 히드록시메타아크릴레이트가 있다.In addition, the acrylic monomer may include a reactive functional group, and examples of the functional group include an amide group, a hydroxyl group, an epoxy group, a silanol group, or an aldehyde group. More specifically, the acrylic monomer further comprising a reactive functional group may be acrylamide, methacrylamide, N-methylacrylamide, N-methylolacrylamide, N-butoxymethylacrylamide, N-methylmethacrylamide, N Butoxymethylmethacrylamide, hydroxyethyl acrylate, hydroxyethyl methacrylate, hydroxypropyl acrylate, hydroxypropyl methacrylate, glycidyl acrylate, glycidyl methacrylate, γ-trimethoxysilane Methacrylate, γ-triethoxysilane methacrylate, acrolein, caprolactone modified hydroxyacrylate or caprolactone modified hydroxymethacrylate.
또한, 상기 반응식 3에서, 공지의 개시제를 사용할 수 있으며, 아조-비스-이소-부틸니트릴(AIBN), 아조비스디메틸벨러로니트릴, 벤조일퍼옥사이드, t-부틸하이드로퍼옥사이드, t-부틸퍼옥시옥타노에이트, t-부틸퍼옥시벤조에이트, 큐민하이드로퍼옥사이드 및 큐밀퍼옥사이드로 이루어진 군에서 선택되는 1종 이상의 화합물을 사용할 수 있다. 이때, 상기 개시제의 첨가량은 전체 화합물 100 중량부에 대하여 0.05 내지 10 중량부일 수 있으며, 바람직하게는 0.3 내지 5 중량부일 수 있다. 또한, 반응온도는 50 ℃ 내지 130 ℃일 수 있으나 이에 한정되지는 않는다.
In addition, in Scheme 3, a known initiator may be used, and azo-bis-iso-butylnitrile (AIBN), azobisdimethylbellonitrile, benzoyl peroxide, t-butylhydroperoxide, t-butylperoxy One or more compounds selected from the group consisting of octanoate, t-butylperoxybenzoate, cumin hydroperoxide and cumyl peroxide can be used. In this case, the amount of the initiator may be 0.05 to 10 parts by weight, preferably 0.3 to 5 parts by weight based on 100 parts by weight of the total compound. In addition, the reaction temperature may be 50 ° C to 130 ° C, but is not limited thereto.
한편, 상기 화학식 1의 화합물이 결합된 폴리올 화합물은 화학식 1의 화합물을 링커와 결합시킨 후, 이를 폴리올과 반응시킨 것으로서; 이때, 상기 폴리올 화합물은 반응성 및 물성 등을 고려하여 중량평균 분자량이 10,000 내지 1,000,000인 것이 바람직하며; 하기 화학식 5 내지 화학식 8로 표시되는 것일 수 있다:On the other hand, the polyol compound to which the compound of Formula 1 is bonded as the compound of Formula 1 is combined with a linker, and then reacted with the polyol; In this case, the polyol compound preferably has a weight average molecular weight of 10,000 to 1,000,000 in consideration of reactivity and physical properties; It may be represented by the following formula (5):
[화학식 5][Chemical Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
상기 화학식 5 내지 화학식 8에서,In Chemical Formulas 5 to 8,
Z는 하기 화학식 b로 표시되고,Z is represented by the following formula b,
[화학식 b][Formula b]
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같다.R 1 to R 10 are the same as defined in Chemical Formula 1.
이때, 상기 화학식 1의 화합물과 결합되는 링커로는 이소시아네이트(-N=C=O)계, 할로아실할로겐화물 및 산무수물을 함유한 화합물로 이루어진 군에서 선택되는 1종 이상을 사용할 수 있다. 바람직하게는, 상기 링커는 이소시아네이트계로서, 톨루엔디이소시아네이트(TDI), 도데실디이소시아네이트(DDI), 헥사메틸렌디이소시아네이트(HDI) 및 트리헥사메틸렌이소시안누레이트트리이소시아네이트(HMTI)로 이루어진 군에서 선택되는 1종 이상의 화합물일 수 있다.In this case, as the linker bonded to the compound of Formula 1, one or more selected from the group consisting of compounds containing isocyanate (-N = C = O), haloacyl halides and acid anhydrides may be used. Preferably, the linker is an isocyanate, selected from the group consisting of toluene diisocyanate (TDI), dodecyl diisocyanate (DDI), hexamethylene diisocyanate (HDI) and trihexamethylene isocyanurate triisocyanate (HMTI). It may be one or more compounds.
또한, 상기 폴리올로는 본 발명이 속하는 기술분야에서 통상적인 것을 사용할 수 있으며; 바람직하게는 아크릴계 폴리올, 알키드계 폴리올 또는 이들의 혼합물을 사용할 수 있다. 또한, 본 발명의 일 구현예에 따르면, 상기 폴리올은 OH값이 15 내지 80 몰%, 유리전이온도 70 내지 130 ℃, 및 불휘발분이 40 내지 60 중량%인 것이 보다 바람직하다.In addition, the polyol may be used as conventional in the art to which the present invention belongs; Preferably, acrylic polyols, alkyd polyols or mixtures thereof can be used. In addition, according to one embodiment of the present invention, the polyol is more preferably OH value of 15 to 80 mol%, glass transition temperature of 70 to 130 ℃, and non-volatile content of 40 to 60% by weight.
또한, 상기 폴리올 화합물은 용매의 존재하에 제조될 수 있으며, 바람직하게는 N,N-디메틸포름아마이드, N,N-디메틸아세트아마이드, 디메틸설폭사이드, 자일렌, 테트라하이드로퓨란, 벤젠, 톨루엔, 아세토니트릴, 디클로로메탄, 에틸아세테이트, 부틸아세테이트, 1,4-다이옥산 및 클로로포름으로 이루어진 군에서 선택되는 1종 이상일 수 있다.
In addition, the polyol compound may be prepared in the presence of a solvent, preferably N, N-dimethylformamide, N, N-dimethylacetamide, dimethylsulfoxide, xylene, tetrahydrofuran, benzene, toluene, aceto It may be one or more selected from the group consisting of nitrile, dichloromethane, ethyl acetate, butyl acetate, 1,4-dioxane and chloroform.
이와 같은, 상기 화학식 1의 화합물, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 상기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물은 상기 바인더 수지 100 중량부에 대하여, 0.1 내지 20 중량부, 바람직하게는 0.1 내지 10중량부, 보다 바람직하게는 0.1 내지 5 중량부로 포함될 수 있다. As such, at least one compound selected from the group consisting of a compound of Formula 1, a polymer compound including the compound of Formula 1 as a repeating unit, and a polyol compound to which the compound of Formula 1 is bonded is 100 wt% of the binder resin. 0.1 to 20 parts by weight, preferably 0.1 to 10 parts by weight, and more preferably 0.1 to 5 parts by weight, based on the parts.
즉, 상기 화합물에 의한 최소한의 효과 발현을 위하여 상기 화합물은 상기 바인더 수지 100 중량부에 대하여 0.1 중량부 이상 포함되는 것이 바람직하다. 또한, 상기 화합물을 과량으로 첨가할 경우 조성물 물성이 나빠 질 수 있고, 그에 따라 도막이 필요 이상으로 단단해지는 등 도막의 물성이 떨어질 수 있는데, 이를 방지하기 위하여, 상기 바인더 수지 100 중량부에 대하여 20 중량부 이하로 포함되는 것이 바람직하다.
That is, the compound is preferably included 0.1 parts by weight or more based on 100 parts by weight of the binder resin in order to express the minimum effect by the compound. In addition, when the compound is added in an excessive amount, the physical properties of the composition may be deteriorated, and thus the physical properties of the coating film may be inferior, such that the coating film is hardened more than necessary. In order to prevent this, 20 parts by weight based on 100 parts by weight of the binder resin may be used. It is preferable to be contained in parts or less.
한편, 본 발명에 따른 도료 조성물은 전술한 성분들 이외에도, 당업계에서 통상적으로 사용되는 첨가제를 더욱 포함할 수 있다.On the other hand, the coating composition according to the present invention may further include an additive commonly used in the art, in addition to the above-described components.
예를 들면, 상기 도료 조성물에는 조성물의 용도, 도포 장소 등에 따라 증점제, 안정제, 분산제 등의 첨가제가 더욱 포함될 수 있다. 이때, 상기 첨가제의 함량은 본 발명에 따른 조성물의 물성을 저하시키기 않는 다양한 범위 내에서 결정할 수 있으므로, 특별히 제한하지 않는다.
For example, the coating composition may further include additives such as thickeners, stabilizers, and dispersants, depending on the use of the composition, the place of application, and the like. At this time, the content of the additive can be determined within various ranges that do not lower the physical properties of the composition according to the present invention, it is not particularly limited.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예들을 제시한다. 그러나 하기의 실시예들은 본 발명을 예시하기 위한 것일 뿐, 본 발명을 이들만으로 한정하는 것은 아니다.Best Mode for Carrying Out the Invention Hereinafter, preferred embodiments are described to facilitate understanding of the present invention. However, the following examples are intended to illustrate the present invention without limiting it thereto.
제조예Manufacturing example 1-1 1-1
실리카-티타니아 복합체의 제조Preparation of Silica-Titania Composites
: TiCl4를 증류수에 부가하여 부분 가수분해 시켜 얻은 TiOCl2 용액(강산성)에 소듐실리케이트 수용액을 첨가하였다. 이때, Si와 Ti의 몰비율이 8:2가 되도록 첨가하였다. 상기 혼합액을 NH4OH와 HCl을 사용하여 pH 7의 조건에 맞춘 후 80 내지 95 ℃에서 2 시간 동안 반응시켰다. 상기 반응 생성물을 여과 및 건조한 후, 이를 900 ℃의 가열로에서 소성하여 실리카-티타니아 복합체를 제조하였다.: An aqueous sodium silicate solution was added to a TiOCl 2 solution (strongly acidic) obtained by partial hydrolysis by adding TiCl 4 to distilled water. At this time, the molar ratio of Si and Ti was added so that it was 8: 2. The mixture was adjusted to pH 7 using NH 4 OH and HCl, and then reacted at 80 to 95 ° C. for 2 hours. The reaction product was filtered and dried, and then fired in a heating furnace at 900 ° C. to prepare a silica-titania composite.
제조예Manufacturing example 1-2 1-2
실리카-티타니아 복합체의 제조Preparation of Silica-Titania Composites
: TiCl4를 증류수에 부가하여 부분 가수분해 시켜 얻은 TiOCl2 용액(강산성)에 소듐실리케이트 수용액을 첨가하였다. 이때, Si와 Ti의 몰비율이 7:3이 되도록 첨가하였다. 상기 혼합액을 NH4OH와 HCl을 사용하여 pH 7의 조건에 맞춘 후 80 내지 95 ℃에서 2 시간 동안 반응시켰다. 상기 반응 생성물을 여과 및 건조한 후, 이를 900 ℃의 가열로에서 소성하여 실리카-티타니아 복합체를 제조하였다.: An aqueous sodium silicate solution was added to a TiOCl 2 solution (strongly acidic) obtained by partial hydrolysis by adding TiCl 4 to distilled water. At this time, the molar ratio of Si and Ti was added so that it was 7: 3. The mixture was adjusted to pH 7 using NH 4 OH and HCl, and then reacted at 80 to 95 ° C. for 2 hours. The reaction product was filtered and dried, and then fired in a heating furnace at 900 ° C. to prepare a silica-titania composite.
제조예Manufacturing example 1-3 1-3
실리카-티타니아 복합체의 제조Preparation of Silica-Titania Composites
: TiCl4를 증류수에 부가하여 부분 가수분해 시켜 얻은 TiOCl2 용액(강산성)에 소듐실리케이트 수용액을 첨가하였다. 이때, Si와 Ti의 몰비율이 9:1이 되도록 첨가하였다. 상기 혼합액을 NH4OH와 HCl을 사용하여 pH 7의 조건에 맞춘 후 80 내지 95 ℃에서 2 시간 동안 반응시켰다. 상기 반응 생성물을 여과 및 건조한 후, 이를 900 ℃의 가열로에서 소성하여 실리카-티타니아 복합체를 제조하였다.: An aqueous sodium silicate solution was added to a TiOCl 2 solution (strongly acidic) obtained by partial hydrolysis by adding TiCl 4 to distilled water. At this time, the molar ratio of Si and Ti was added so that it was 9: 1. The mixture was adjusted to pH 7 using NH 4 OH and HCl, and then reacted at 80 to 95 ° C. for 2 hours. The reaction product was filtered and dried, and then fired in a heating furnace at 900 ° C. to prepare a silica-titania composite.
제조예Manufacturing example 1-4 1-4
실리카-티타니아 복합체의 제조Preparation of Silica-Titania Composites
: TiCl4를 증류수에 부가하여 부분 가수분해 시켜 얻은 TiOCl2 용액(강산성)에 소듐실리케이트 수용액을 첨가하였다. 이때, Si와 Ti의 몰비율이 6.5:3.5가 되도록 첨가하였다. 상기 혼합액을 NH4OH와 HCl을 사용하여 pH 7의 조건에 맞춘 후 80 내지 95 ℃에서 2 시간 동안 반응시켰다. 상기 반응 생성물을 여과 및 건조한 후, 이를 900 ℃의 가열로에서 소성하여 실리카-티타니아 복합체를 제조하였다.: An aqueous sodium silicate solution was added to a TiOCl 2 solution (strongly acidic) obtained by partial hydrolysis by adding TiCl 4 to distilled water. At this time, the molar ratio of Si and Ti was added to be 6.5: 3.5. The mixture was adjusted to pH 7 using NH 4 OH and HCl, and then reacted at 80 to 95 ° C. for 2 hours. The reaction product was filtered and dried, and then fired in a heating furnace at 900 ° C. to prepare a silica-titania composite.
제조예Manufacturing example 1-5 1-5
실리카-티타니아 복합체의 제조Preparation of Silica-Titania Composites
: TiCl4를 증류수에 부가하여 부분 가수분해 시켜 얻은 TiOCl2 용액(강산성)에 소듐실리케이트 수용액을 첨가하였다. 이때, Si와 Ti의 몰비율이 9.5:0.5가 되도록 첨가하였다. 상기 혼합액을 NH4OH와 HCl을 사용하여 pH 7의 조건에 맞춘 후 80 내지 95 ℃에서 2 시간 동안 반응시켰다. 상기 반응 생성물을 여과 및 건조한 후, 이를 900 ℃의 가열로에서 소성하여 실리카-티타니아 복합체를 제조하였다.
: An aqueous sodium silicate solution was added to a TiOCl 2 solution (strongly acidic) obtained by partial hydrolysis by adding TiCl 4 to distilled water. At this time, the molar ratio of Si and Ti was added so that it was 9.5: 0.5. The mixture was adjusted to pH 7 using NH 4 OH and HCl, and then reacted at 80 to 95 ° C. for 2 hours. The reaction product was filtered and dried, and then fired in a heating furnace at 900 ° C. to prepare a silica-titania composite.
제조예Manufacturing example 2-1 2-1
{1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실)-3-메틸-1-피페라진일]-5-메틸-4-옥소-3-퀴놀린카복실산} 제조{1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (10,11-epoxy-2,6-dihydroxy-4,8-dioxoundecyl) -3- Methyl-1-piperazinyl] -5-methyl-4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근 삼구 플라스크에 온도계와 교반 시설을 설치하고, 여기에 N,N-디메틸포름아미드 15.0 ml를 투입한 후 실온에서 1-사이클로프로필-6-플루오로-1,4-디히드로-5-메틸-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산 30.4 mg을 첨가하여 실온에서 10분 동안 서서히 교반하였다. 여기에 글리세롤디글리시딜에테르 17.2 mg을 넣고 교반하였다. 반응물은 N,N-디메틸포름아미드 1.2 ml로 세척하고 60 ℃로 온도를 조절한 다음 5시간 반응시켰다. 이후 냉각시킨 다음 20 ℃에서 10분 동안 교반하였다. 반응물은 물층에서 결정화된 상태로 수득하고, 건조하여 35.0 mg의 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(10,11-에폭시-2,6-디히드록시-δ4,8-디옥사운데실)-3-메틸-1-피페라진일]-5-메틸-4-옥소-3-퀴놀린카복실산을 수득하였다.: A 50 ml round three-necked flask was equipped with a thermometer and a stirring facility, 15.0 ml of N, N-dimethylformamide was added thereto, and then 1-cyclopropyl-6-fluoro-1,4-dihydro-5 at room temperature. 30.4 mg of -methyl-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid was added and stirred slowly at room temperature for 10 minutes. 17.2 mg of glycerol diglycidyl ether was added thereto and stirred. The reaction was washed with 1.2 ml of N, N-dimethylformamide and the temperature was adjusted to 60 ° C., followed by reaction for 5 hours. It was then cooled and stirred at 20 ° C for 10 minutes. The reaction was obtained in crystallized state in the water layer and dried to give 35.0 mg of 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (10,11-epoxy-2,6-di Hydroxy-δ4,8-dioxoundesyl) -3-methyl-1-piperazinyl] -5-methyl-4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.05 (3H, d), 1.20~1.44 (4H, m), 2.40 (3H, s), 2.50~3.00 (7H, m), 3.10~4.00 (16H, m), 7.39 (1H, d), 8.81 (1H, s). 1 H-NMR (DMSO-d 6 ) δ1.05 (3H, d), 1.20-1.44 (4H, m), 2.40 (3H, s), 2.50-3.00 (7H, m), 3.10-4.00 (16H, m), 7.39 (1 H, d), 8.81 (1 H, s).
제조예Manufacturing example 2-2 2-2
{1-에틸-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조(1-ethyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3 -Methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 2,6-디메틸피페라진 10.0 ml에 1-에틸-6,8-디플루오로-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산 39.4 mg를 혼합하고, 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜메타크릴레이트 22.0 mg을 넣고 실온에서 교반한 다음 반응물을 2,6-디메틸피페라진 2.0 ml로 세척하였다. 이후 40 ℃에서 8시간 반응시키고 다시 실온으로 냉각시킨 후 8시간 동안 교반 하였다. 물층에서 결정화된 반응물을 수득하고 건조하여 25 mg의 1-에틸-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산을 수득하였다.: 1-ethyl-6,8-difluoro-1,4-dihydro-7- (3-methyl-1-piperazinyl) in 10.0 ml of 2,6-dimethylpiperazine after installing a 50 ml round flask 39.4 mg of 4-oxo-3-quinolinecarboxylic acid were mixed and stirred slowly at room temperature for 10 minutes. 22.0 mg of glycidyl methacrylate was added thereto, the mixture was stirred at room temperature, and the reaction was washed with 2.0 ml of 2,6-dimethylpiperazine. After reacting for 8 hours at 40 ℃ and cooled to room temperature again and stirred for 8 hours. Obtained crystallized reactant in water layer and dried to give 25 mg of 1-ethyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa -5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.10 (3H, d), 1.58 (3H, t), 1.93 (3H, s), 2.52~3.00 (5H, m), 3.23~3.41 (4H, m), 3.90~4.38 (5H, m), 5.58 (1H, d), 6.15 (1H, d), 7.72 (1H, s), 8.62 (1H, s) 1 H-NMR (DMSO-d 6 ) δ 1.10 (3H, d), 1.58 (3H, t), 1.93 (3H, s), 2.52-3.00 (5H, m), 3.23-3.41 (4H, m) , 3.90-4.38 (5H, m), 5.58 (1H, d), 6.15 (1H, d), 7.72 (1H, s), 8.62 (1H, s)
제조예Manufacturing example 2-3 2-3
{8-에틸-5,8-디히드로-2-{4-[2-히드록시-3-(4-노닐페녹시)프로필]-1-피페라진일}-5-옥소피리도[2,3-d]피리미딘-6-카복실산} 제조{8-ethyl-5,8-dihydro-2- {4- [2-hydroxy-3- (4-nonylphenoxy) propyl] -1-piperazinyl} -5-oxopyrido [2, 3-d] pyrimidine-6-carboxylic acid}
: 50 ml 둥근플라스크를 설치 후 디메틸설폭사이드 12.0 ml에 8-에틸-5,8-디히드로-5-옥소-2-(1-피페라진일)피리도{2,3-d}피리미딘-6-카복실릭산 38.0 mg을 혼합하고, 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜논닐페닐에테르 18.0 mg을 넣고 다시 실온에서 교반한 다음 디메틸설폭사이드 12 ml로 세척하였다. 50 ℃에서 11시간 방치한 다음 20 ℃에서 10분간 교반하였다. 반응물은 메틸렌클로리드와 수층, 이소프로필알콜에서 결정화하여 여과하고 이를 건조시킨 후 생성물 37.2 mg의 8-에틸-5,8-디히드로-2-{4-[2-히드록시-3-(4-노닐페녹시)프로필]-1-피페라진일}-5-옥소피리도[2,3-d]피리미딘-6-카복실산을 수득하였다.: 8 ml of 8-ethyl-5,8-dihydro-5-oxo-2- (1-piperazinyl) pyrido®2,3-dpyrimidine- in 12.0 ml of dimethyl sulfoxide after installing a 50 ml round flask. 38.0 mg of 6-carboxylic acid was mixed and stirred slowly at room temperature for 10 minutes. 18.0 mg of glycidylnonylphenyl ether was added thereto, and the mixture was stirred at room temperature and washed with 12 ml of dimethyl sulfoxide. After standing at 50 ° C. for 11 hours, the mixture was stirred at 20 ° C. for 10 minutes. The reaction product was crystallized from methylene chloride, an aqueous layer, isopropyl alcohol, filtered and dried, and then 37.2 mg of 8-ethyl-5,8-dihydro-2- {4- [2-hydroxy-3- (4) was obtained. -Nonylphenoxy) propyl] -1-piperazinyl} -5-oxopyrido [2,3-d] pyrimidine-6-carboxylic acid was obtained.
1H-NMR (DMSO-d6) δ0.88 (3H, t), 1.10~1.70 (17H, m), 2.45~3.05 (10H, m), 3.35~3.55 (4H, m), 3.92~4.12 (3H, m), 6.76, 7.05 (4H, ABq), 8.58 (1H, s), 8.87 (1H, s). 1 H-NMR (DMSO-d 6 ) δ0.88 (3H, t), 1.10 to 1.70 (17H, m), 2.45 to 3.05 (10H, m), 3.35 to 3.55 (4H, m), 3.92 to 4.12 ( 3H, m), 6.76, 7.05 (4H, ABq), 8.58 (1H, s), 8.87 (1H, s).
제조예Manufacturing example 2-4 2-4
{시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3,5-디메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조{Cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo- 6-heptenyl) -3,5-dimethyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 N,N-디메틸아세트아미드 5.0 ml에 시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-(3,5-디메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산 43.7 mg를 혼합하고 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜메타크릴레이트 17.5 mg을 넣고 실온에서 교반한 다음 N,N-디메틸아세트아미드 3.1 ml로 세척하였다. 75 ℃에서 6시간 방치하고 20 ℃에서 10분간 교반하여 주었다. 이후 반응물은 메틸렌클로리드와 수층, 이소프로필알콜에서 결정화하여 여과한 다음 건조시켜 29.3 mg의 시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3,5-디메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산로 수득하였다. : 50 ml round flask was installed, and 5.0 ml of N, N-dimethylacetamide was added to cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7- (3,5 43.7 mg of -dimethyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid were mixed and stirred slowly at room temperature for 10 minutes. 17.5 mg of glycidyl methacrylate was added thereto, stirred at room temperature, and washed with 3.1 ml of N, N-dimethylacetamide. It left for 6 hours at 75 degreeC, and stirred for 10 minutes at 20 degreeC. The reaction was then crystallized from methylene chloride, an aqueous layer, isopropyl alcohol, filtered and dried to give 29.3 mg of cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7 -[4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3,5-dimethyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid Obtained.
1H-NMR (DMSO-d6) δ1.07 (6H, d), 1.20~1.45 (4H, m), 1.96 (3H, s), 2.50~3.00 (4H, m), 3.20~3.60 (5H, m), 4.00~4.40 (3H, m), 5.67 (1H, s), 6.20 (1H, s), 8.60 (1H, s). 1 H-NMR (DMSO-d 6 ) δ1.07 (6H, d), 1.20-1.45 (4H, m), 1.96 (3H, s), 2.50-3.00 (4H, m), 3.20-3.60 (5H, m), 4.00-4.40 (3H, m), 5.67 (1H, s), 6.20 (1H, s), 8.60 (1H, s).
제조예Manufacturing example 2-5 2-5
{1-(2,4-디플루오로페닐)-6-플루오로-1,4-디히드로-7-[4-(2-히드록시-5-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조{1- (2,4-Difluorophenyl) -6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-5-methyl-4-oxa-5-oxo-6 -Heptenyl) -3-methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 N,N-디메틸포름아미드 10.0 ml에 1-(2,4-디플로로페닐)-6-플로로-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실릭산 49.2 mg을 혼합하고 실온에서 10분간 교반하였다. 여기에 글리시딜메타아크릴레이트 14.3 mg를 투여하고 실온에서 교반한 다음 N,N-디메틸포름아미드 5.0 ml로 세척하였다. 80 ℃에서 9시간 방치한 다음 20 ℃에서 10분간 교반하여 주었다. 반응물은 메틸렌클로리드와 수층, 이소프로필알콜에서 결정형으로 여과하고 건조시킨 후 41.0 mg의 1-(2,4-디플루오로페닐)-6-플루오로-1,4-디히드로-7-[4-(2-히드록시-5-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산을 수득하였다.: A 50 ml round flask was placed in 10.0 ml of N, N-dimethylformamide and 1- (2,4-difluorophenyl) -6-fluoro-1,4-dihydro-7- (3-methyl- 49.2 mg of 1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid was mixed and stirred at room temperature for 10 minutes. 14.3 mg of glycidyl methacrylate was added thereto, stirred at room temperature, and washed with 5.0 ml of N, N-dimethylformamide. After standing at 80 ° C. for 9 hours, the mixture was stirred at 20 ° C. for 10 minutes. The reaction was filtered through a methylene chloride, an aqueous layer, isopropyl alcohol, crystalline form, dried, and then 41.0 mg of 1- (2,4-difluorophenyl) -6-fluoro-1,4-dihydro-7- [ 4- (2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.06 (3H, d), 1.95 (3H, s), 2.50~3.00 (5H, m), 3.20~3.40 (4H, m), 4.00~4.40 (3H, m), 5.58 (1H, s), 6.15 (1H, s), 6.45~6.85 (4H, m), 7.89 (1H, d), 8.62 (1H, s). 1 H-NMR (DMSO-d 6 ) δ1.06 (3H, d), 1.95 (3H, s), 2.50-3.00 (5H, m), 3.20-3.40 (4H, m), 4.00-4.40 (3H, m), 5.58 (1H, s), 6.15 (1H, s), 6.45-6.85 (4H, m), 7.89 (1H, d), 8.62 (1H, s).
제조예Manufacturing example 2-6 2-6
{1-사이클로프로필-6-플루오로-7-[4-(3-도데카플루오로-2-히드록시-4-옥사운데실)-3-메틸-1-피페라진일]-1,4-디히드로-5-메틸-4-옥소-3-퀴놀린카복실산} 제조{1-cyclopropyl-6-fluoro-7- [4- (3-dodecafluoro-2-hydroxy-4-oxoundecyl) -3-methyl-1-piperazinyl] -1,4 -Dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 N,N-디메틸포름아미드 12.2 ml에 1-싸이클로프로필-6-플로로-5-메틸-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실릭산 39.4 mg을 넣고 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜도데카플로로헵틸에테르 37.3 mg을 투여하고 실온에서 교반한 다음 N,N-디메틸포름아미드 12.2 ml로 세척하였다. 70 ℃에서 6시간 방치한 다음 20 ℃에서 10분간 교반하였다. 반응물은 에테르와 수층, 이소프로필알콜에서 결정화시켜 여과하고, 헥산으로 세척한 다음 이를 건조시켜 43.1 mg의 1-사이클로프로필-6-플루오로-7-[4-(3-도데카플루오로-2-히드록시-4-옥사운데실)-3-메틸-1-피페라진일]-1,4-디히드로-5-메틸-4-옥소-3-퀴놀린카복실산을 수득하였다. : 1 ml cyclopropyl-6-fluoro-5-methyl-1,4-dihydro-7- (3-methyl-1-piperazine) in 12.2 ml of N, N-dimethylformamide after installing a 50 ml round flask. 39.4 mg of 1) -4-oxo-3-quinolinecarboxylic acid was added thereto and stirred slowly at room temperature for 10 minutes. To this was administered 37.3 mg of glycidyl dodecafluoroheptyl ether, stirred at room temperature, and washed with 12.2 ml of N, N-dimethylformamide. After standing at 70 ° C. for 6 hours, the mixture was stirred at 20 ° C. for 10 minutes. The reaction was crystallized from ether, aqueous layer, isopropyl alcohol, filtered, washed with hexane and dried to give 43.1 mg of 1-cyclopropyl-6-fluoro-7- [4- (3-dodecafluoro-2 -Hydroxy-4-oxoundecyl) -3-methyl-1-piperazinyl] -1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.06 (3H, d), 1.20~1.45 (4H, m), 2.40 (3H, s), 2.50~3.00 (5H, m), 3.20~4.10 (10H, m), 5.80~6.20 (1H, m) 7.40 (1H, d), 8.82 (1H, s). 1 H-NMR (DMSO-d 6 ) δ1.06 (3H, d), 1.20-1.45 (4H, m), 2.40 (3H, s), 2.50-3.00 (5H, m), 3.20-4.10 (10H, m), 5.80-6.30 (1 H, m) 7.40 (1 H, d), 8.82 (1 H, s).
제조예Manufacturing example 2-7 2-7
{1-에틸-6,8-디플로로-1,4-디히드로-7-{4-[2-히드록시-3-(메톡시)페녹시프로필}-3-메틸-1-피페라진일}-4-옥소-3-퀴놀린카복실산} 제조{1-ethyl-6,8-difluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (methoxy) phenoxypropyl} -3-methyl-1-piperazine Preparation of -4--4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 N,N-디메틸포름아미드 13.0 ml에 1-에틸-6,8-디플로로-1,4-디히드로-7-(3-메틸-1-피페라진일)-4-옥소-3-퀴놀린카복실산 30.4 mg을 혼합하고 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜4-메톡시페닐에테르 19.7 mg을 첨가하여 실온에서 교반한 다음 N,N-디메틸포름아미드 10.2 ml로 세척하였다. 80 ℃에서 7시간 방치한 다음 15 ℃에서 5분간 교반하였다. 이후 디옥산과 수층, 에틸알콜상에서 결정호하여 여과한 다음 헥산으로 세척, 건조하여 17.3 mg의 1-에틸-6,8-디플로로-1,4-디히드로-7-{4-[2-히드록시-3-(메톡시)페녹시프로필}-3-메틸-1-피페라진일}-4-옥소-3-퀴놀린카복실산을 수득하였다. : 1-ethyl-6,8-difluoro-1,4-dihydro-7- (3-methyl-1-piperazinyl) in 13.0 ml of N, N-dimethylformamide after installing a 50 ml round flask. 30.4 mg of 4-oxo-3-quinolinecarboxylic acid were mixed and stirred slowly at room temperature for 10 minutes. 19.7 mg of glycidyl4-methoxyphenylether was added thereto, stirred at room temperature, and washed with 10.2 ml of N, N-dimethylformamide. After standing at 80 ° C. for 7 hours, the mixture was stirred at 15 ° C. for 5 minutes. After filtration with dioxane, an aqueous layer and ethyl alcohol, crystallization, washing with hexane, drying, and 17.3 mg of 1-ethyl-6,8-difluoro-1,4-dihydro-7- {4- [2 -Hydroxy-3- (methoxy) phenoxypropyl} -3-methyl-1-piperazinyl} -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.06(3H, d),1.58 (3H, t), 2.50~3.00 (5H, m), 3.20~3.40 (4H, m), 3.70 (3H, s), 3.90~4.40 (5H, m), 6.60~6.80 (4H, m), 7.68 (1H, s), 8.60 (1H, s). 1 H-NMR (DMSO-d 6 ) δ1.06 (3H, d), 1.58 (3H, t), 2.50-3.00 (5H, m), 3.20-3.40 (4H, m), 3.70 (3H, s) , 3.90-4.40 (5H, m), 6.60-6.80 (4H, m), 7.68 (1H, s), 8.60 (1H, s).
제조예Manufacturing example 2-8 2-8
{1-에틸-6-플로로-1,4-디히드로-7-{4-[2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필]-1-피페라진일}-4-옥소-3-퀴놀린카복실산} 제조{1-ethyl-6-fluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (toluene-4-sulfonyloxy) -propyl] -1-piperazinyl}- 4-oxo-3-quinolinecarboxylic acid}
: 100 ml 둥근플라스크를 설치 후 N,N-디메틸포름아미드 50 ml에서 1-에틸-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 39.4 mg을 혼합하여 실온에서 20분간 서서히 교반하였다. 여기에 글리시딜 토실레이트 14.4 mg을 첨가하여 실온에서 교반한 다음 N,N-디메틸포름아미드 30.0 ml로 세척하였다. 80 ℃에서 5시간 방치한 다음 25 ℃에서 10분간 교반하였다. 반응물은 칼럼 클로마토그라피(20gm silica, 10% 에틸아세테이트/헥산)을 통과시켜 결정화한 다음 여과하였고, 이를 건조시켜 1-에틸-6-플로로-1,4-디히드로-7-{4-[2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필]-1-피페라진일}-4-옥소-3-퀴놀린카복실산 11.2 mg을 수득하였다. : 100 ml round flask was installed, and 50 ml of 1, ethyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3- in 50 ml of N, N-dimethylformamide. 39.4 mg of quinolinecarboxylic acid were mixed and slowly stirred at room temperature for 20 minutes. 14.4 mg of glycidyl tosylate was added thereto, stirred at room temperature, and washed with 30.0 ml of N, N-dimethylformamide. After standing at 80 ° C. for 5 hours, the mixture was stirred at 25 ° C. for 10 minutes. The reaction was crystallized by passing through column chromatography (20 gm silica, 10% ethyl acetate / hexane), and then filtered and dried to obtain 1-ethyl-6-fluoro-1,4-dihydro-7- {4-. 11.2 mg of [2-hydroxy-3- (toluene-4-sulfonyloxy) -propyl] -1-piperazinyl} -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.60 (3H, t), 2.40 (3H, s), 2.50~2.85 (6H, m), 3.20~3.40 (4H, m), 3.90~4.40 (5H, m), 6.82 (1H, d), 7.40~7.85 (5H, m), 8.60 (1H, s). 1 H-NMR (DMSO-d 6 ) δ 1.60 (3H, t), 2.40 (3H, s), 2.50-2.85 (6H, m), 3.20-3.40 (4H, m), 3.90-4.40 (5H, m), 6.82 (1 H, d), 7.40-7.85 (5 H, m), 8.60 (1 H, s).
제조예Manufacturing example 2-9 2-9
{1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조(1-Cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-pipe Razinyl] -4-oxo-3-quinolinecarboxylic acid}
: 100 ml 둥근플라스크를 설치 후 N,N-디메틸아세트아미드 50 ml에 1-싸이클로프로필-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 39.4 mg을 혼합하여 실온에서 30분간 서서히 교반하였다. 여기에 글리시딜메타크릴레이트 17.5 mg을 넣고, 실온에서 교반한 다음 N,N-디메틸아세트아미드 1.2 ml로 세척하였다. 이후 80 ℃에서 19시간 방치한 다음 25 ℃에서 30분간 교반하고 메틸렌클로리드와 수층 및 이소프로필알콜에서 결정화하여 여과하였다. 이를 건조하여 1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산 53.3mg을 수득하였다. : 100 ml round flask was placed in 50 ml of N, N-dimethylacetamide and 1-cyclopropyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3 39.4 mg of quinolinecarboxylic acid were mixed and stirred slowly at room temperature. 17.5 mg of glycidyl methacrylate was added thereto, stirred at room temperature, and washed with 1.2 ml of N, N-dimethylacetamide. Thereafter, the mixture was left at 80 ° C. for 19 hours, stirred at 25 ° C. for 30 minutes, crystallized from methylene chloride, an aqueous layer and isopropyl alcohol, and filtered. It was dried to yield 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1 53.3 mg of piperazinyl] -4-oxo-3-quinolinecarboxylic acid were obtained.
1H-NMR (CDCl3) δ1.20~1.41 (4H, m), 2.05 (3H, s), 2.51 (2H, d), 2.59 (2H, t), 2.85 (2H, d), 3.25~3.60 (5H, m), 4.05 (2H, m), 4.30 (1H, m), 5.58 (1H, s), 6.15 (1H, s), 7.28 (1H, d), 8.05 (1H, d), 8.80 (1H, s) 1 H-NMR (CDCl 3 ) δ1.20-1.41 (4H, m), 2.05 (3H, s), 2.51 (2H, d), 2.59 (2H, t), 2.85 (2H, d), 3.25-3.60 (5H, m), 4.05 (2H, m), 4.30 (1H, m), 5.58 (1H, s), 6.15 (1H, s), 7.28 (1H, d), 8.05 (1H, d), 8.80 ( 1H, s)
제조예Manufacturing example 2-10 2-10
{1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피퍼라진일]-4-옥소-3-퀴놀린카복실산} 제조{1-ethyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazine Production] -4-oxo-3-quinolinecarboxylic acid}
: 100 ml 둥근플라스크를 설치 후 N,N-디메틸아세트아미드 50 ml에 1-에틸-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 39.4 mg을 넣어 실온에서 10분간 서서히 교반하였다. 여기에 글리시딜메타크릴레이트 17.5 mg을 첨가하여 실온에서 교반한 다음 N,N-디메칠아세트아미드 11.2 ml로 세척하였다. 이후 80 ℃에서 15시간 방치한 다음 25 ℃에서 1시간 동안 교반하였다. 반응물은 칼럼 클로마토그라피(20gm silica, 10% 에틸아세테이트/헥산)를 통과시키고, 메틸렌클로리드와 수층 및 이소프로필알콜에서 결정화시킨 다음 여과하였다. 여과물은 건조하여 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산 36 mg을 수득하였다. : 100 ml round flask was placed in 50 ml of N, N-dimethylacetamide and then 1-ethyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3- 39.4 mg of quinolinecarboxylic acid was added thereto and stirred slowly at room temperature for 10 minutes. 17.5 mg of glycidyl methacrylate was added thereto, stirred at room temperature, and washed with 11.2 ml of N, N-dimethylacetamide. After standing at 80 ℃ for 15 hours and then stirred at 25 ℃ for 1 hour. The reaction was passed through column chromatography (20 gm silica, 10% ethyl acetate / hexane), crystallized from methylene chloride, an aqueous layer, and isopropyl alcohol, and filtered. The filtrate was dried to give 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl)- 36 mg of 1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid were obtained.
1H-NMR (CDCl3) δ1.48 (3H, t), 1.93 (3H, s), 2.51 (2H, d), 2.59~2.82 (4H, m), 3.10~3.40 (4H, t), 3.45 (2H, m), 3.90~4.28 (4H, m), 5.58 (1H, d), 6.05 (1H, d), 6.75 (1H, S), 7.62 (1H, d), 8.58 (1H, s) 1 H-NMR (CDCl 3 ) δ 1.48 (3H, t), 1.93 (3H, s), 2.51 (2H, d), 2.59-2.82 (4H, m), 3.10-3.40 (4H, t), 3.45 (2H, m), 3.90-4.28 (4H, m), 5.58 (1H, d), 6.05 (1H, d), 6.75 (1H, S), 7.62 (1H, d), 8.58 (1H, s)
제조예Manufacturing example 2-11 2-11
{8-에틸-5,8-디히드로-2-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-5-옥소--피리도[2,3-d]피리미딘-6-카복실산} 제조{8-ethyl-5,8-dihydro-2- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -5- Preparation of oxo-pyrido [2,3-d] pyrimidine-6-carboxylic acid}
: 100 ml 둥근플라스크를 설치 후 N,N-디메틸아세트아미드 50 ml에 8-에틸-5,8-디히드로-5-옥소-2-(1-피페라진일)-피리도[2,3-d]피리미딘-6-카복실산 38.2 mg을 혼합하고, 실온에서 50분간 서서히 교반하였다. 여기에 글리시딜메타크릴레이트 15.0 mg을 첨가하고 실온에서 교반한 다음 N,N-디메틸아세트아미드 10 ml로 세척하였다. 이후 70 ℃에서 15시간 방치한 다음 20 ℃에서 1시간동안 교반하였다. 반응물은 칼럼 클로마토그라피(20gm silica, 10% 에틸아세테이트/헥산)를 통과시키고, 메틸렌클로리드와 수층 및 이소프로필알콜에서 결정화하여 여과한 다음 건조시킨 후 8-에틸-5,8-디히드로-2-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-5-옥소--피리도[2,3-d]피리미딘-6-카복실산 27 mg을 수득하였다.: 100 ml round flask was placed in 50 ml of N, N-dimethylacetamide and 8-ethyl-5,8-dihydro-5-oxo-2- (1-piperazinyl) -pyrido [2,3- d] 38.2 mg of pyrimidine-6-carboxylic acid was mixed and stirred slowly at room temperature for 50 minutes. 15.0 mg of glycidyl methacrylate was added thereto, stirred at room temperature, and washed with 10 ml of N, N-dimethylacetamide. After standing at 70 ℃ for 15 hours and then stirred at 20 ℃ for 1 hour. The reaction was passed through column chromatography (20 gm silica, 10% ethyl acetate / hexane), crystallized from methylene chloride, an aqueous layer and isopropyl alcohol, filtered and dried, and then 8-ethyl-5,8-dihydro- 2- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -5-oxo-pyrido [2,3-d] 27 mg of pyrimidine-6-carboxylic acid was obtained.
1H-NMR (DMSO-d6) δ1.58 (3H, s), 1.95 (3H, s), 2.50~2.85 (6H, m), 3.20~3.50 (4H, m), 3.90~4.40 (5H, m), 5.60 (1H, s), 6.14 (1H, s), 8.62 (1H, s), 8.87 (1H, s). 1 H-NMR (DMSO-d 6 ) δ 1.58 (3H, s), 1.95 (3H, s), 2.50 to 2.85 (6H, m), 3.20 to 3.50 (4H, m), 3.90 to 4.40 (5H, m), 5.60 (1 H, s), 6.14 (1 H, s), 8.62 (1 H, s), 8.87 (1 H, s).
제조예Manufacturing example 2-12 2-12
{1-에틸-6-플로로-1,4-디히드로-7-[4-(1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조Preparation of {1-ethyl-6-fluoro-1,4-dihydro-7- [4- (1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 질소조건에서 1-에틸-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 500 mg(1.567 mmol)에 클로로포름 30 ml을 가한 다음 트리에틸아민 0.436 ml(3.134 mmol)을 투입하여 실온에서 10분간 교반하였다. 용기내부온도를 -10 ℃로 유지하면서 아크릴로일클로라이드 0.127 ml(1.567 mmol)을 서서히 적가하여 반응시켰다. 여기에 질소하에서 -10 ℃로 3시간 반응시키고, 증류수를 가한 다음 디클로로메탄으로 추출하였다. 이를 농축한 다음 크로마토그라피(20gm silica, 7% MeOH/CH2Cl2)를 실시하여 1-에틸-6-플로로-1,4-디히드로-7-[4-(1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산을 수득하였다.: 500 mg (1.567 mmol) of 1-ethyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid under nitrogen conditions after installing a 50 ml round flask 30 ml of chloroform was added thereto, and 0.436 ml (3.134 mmol) of triethylamine was added thereto, followed by stirring at room temperature for 10 minutes. 0.127 ml (1.567 mmol) of acryloyl chloride was slowly added dropwise while maintaining the temperature inside the vessel at -10 ° C. The mixture was reacted at -10 DEG C for 3 hours under nitrogen, distilled water was added, followed by extraction with dichloromethane. This was concentrated and chromatographed (20gm silica, 7% MeOH / CH 2 Cl 2 ) to give 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (1-oxo-2- Propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (CDCl3) δ1.48 (3H, t), 3.20 (4H, t), 3.42 (4H, t), 4.32 (2H, q), 5.55 (1H, t), 6.12 (1H, t), 6.62 (1H, t), 7.02 (1H, s), 7.75 (1H, s), 8.85 (1H, s) 1 H-NMR (CDCl 3 ) δ 1.48 (3H, t), 3.20 (4H, t), 3.42 (4H, t), 4.32 (2H, q), 5.55 (1H, t), 6.12 (1H, t ), 6.62 (1H, t), 7.02 (1H, s), 7.75 (1H, s), 8.85 (1H, s)
제조예Manufacturing example 2-13 2-13
{1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(2-메틸-1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조{1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-methyl-1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3 -Quinolinecarboxylic acid}
: 50 ml 둥근 3구 플라스크에 질소 기류하에서 1-사이클로프로필-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 700 mg(2.024 mmol)을 가하고, 클로로포름 30 ml 및 피리딘 0.491 ml(3 mmol)을 넣고 실온에서 10분간 교반하였다. 용기 내부 온도를 -10 ℃로 유지하면서 메타크릴로일클로라이드 0.197 ml(2.024 mmol)을 서서히 적가하였다. 3시간 반응 후 증류수를 가하고, 디클로로메탄으로 추출 후 농축한 다음 크로마토그라피(20gm silica, 7% MeOH/CH2Cl2)를 실시하여 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(2-메틸-1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산을 수득하였다.: 700 mg (2.024) of 1-cyclopropyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid under a stream of nitrogen in a 50 ml round three-necked flask mmol) was added, and 30 ml of chloroform and 0.491 ml (3 mmol) of pyridine were added and stirred at room temperature for 10 minutes. 0.197 ml (2.024 mmol) of methacryloylchloride was slowly added dropwise while maintaining the temperature inside the vessel at −10 ° C. After reaction for 3 hours, distilled water was added, extracted with dichloromethane, concentrated, and then subjected to chromatography (20gm silica, 7% MeOH / CH 2 Cl 2 ) to 1-cyclopropyl-6-fluoro-1,4-dihydro. -7- [4- (2-methyl-1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid was obtained.
1H-NMR (CDCl3) δ1.20 (2H, m), 1.41 (2H, m), 2.00 (3H, s), 3.30 (4H, t), 3.35 (1H, m), 3.50 (1H, m), 3.95 (2H, d), 5.20 (2H, d) 7.42 (1H, d), 8.00 (1H, d), 8.90 (1H, s) 1 H-NMR (CDCl 3 ) δ 1.20 (2H, m), 1.41 (2H, m), 2.00 (3H, s), 3.30 (4H, t), 3.35 (1H, m), 3.50 (1H, m ), 3.95 (2H, d), 5.20 (2H, d) 7.42 (1H, d), 8.00 (1H, d), 8.90 (1H, s)
제조예Manufacturing example 2-14 2-14
{1-에틸-6-플로로-1,4-디히드로-7-[4-(4-비닐벤질)-1-피페라진일]-4-옥소-3-퀴놀린카복실산} 제조Preparation of {1-ethyl-6-fluoro-1,4-dihydro-7- [4- (4-vinylbenzyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid}
: 50 ml 둥근플라스크를 설치 후 질소 기류하에서 1-에틸-6-플로로-1,4-디히드로-7-(1-피페라진일)-4-옥소-3-퀴놀린카복실산 400 mg(1.252 mmol)을 클로로포름 30 ml에 혼합하고, 트리에틸아민 0.349 ml(2.505 mmol)를 첨가하여 실온에서 10분간 교반하였다. 용기내부온도를 -10 ℃로 유지하면서 비닐벤질클로라이드 0.177 ml(1.252 mmol)을 서서히 적가하였다. 질소기류하에서 -10℃를 유지하면서 3시간 반응시키고, 증류수를 가한 다음 디클로로메탄으로 추출하였다. 추출물은 농축한 다음 크로마토그라피(20gm silica, 5% MeOH/CH2Cl2)를 실시하여 1-에틸-6-플로로-1,4-디히드로-7-[4-(4-비닐벤질)-1-피페라진일]-4-옥소-3-퀴놀린카복실산 501 mg (91.9 %)을 수득하였다.: 400 mg (1.252 mmol) of 1-ethyl-6-fluoro-1,4-dihydro-7- (1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid under nitrogen stream after installing a 50 ml round flask ) Was mixed with 30 ml of chloroform, and 0.349 ml (2.505 mmol) of triethylamine were added and stirred at room temperature for 10 minutes. 0.177 ml (1.252 mmol) of vinylbenzylchloride was slowly added dropwise while maintaining the temperature inside the vessel at -10 ° C. The mixture was reacted for 3 hours while maintaining the temperature at −10 ° C. under a nitrogen stream, and distilled water was added thereto, followed by extraction with dichloromethane. The extract was concentrated and chromatographed (20gm silica, 5% MeOH / CH 2 Cl 2 ) to give 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (4-vinylbenzyl) 501 mg (91.9%) of 1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid were obtained.
NMR (CDCl3) δ1.48 (3H, t), 3.20 (4H, t), 3.42 (4H, t), 4.55 (2H, q), 5.18 (2H, s), 5.61 (2H, d), 6.63 (1H, m) 7.01 (2H, d), 7.10 (1H, d), 7.18 (2H, d), 7.81 (1H, d), 8.87 (1H, s)NMR (CDCl 3 ) δ 1.48 (3H, t), 3.20 (4H, t), 3.42 (4H, t), 4.55 (2H, q), 5.18 (2H, s), 5.61 (2H, d), 6.63 (1H, m) 7.01 (2H, d), 7.10 (1H, d), 7.18 (2H, d), 7.81 (1H, d), 8.87 (1H, s)
제조예Manufacturing example 2-15 2-15
화학식 2의 중합체 제조(화학식 1의 화합물을 단량체로 한 단일 중합체)Preparation of Polymer of Formula 2 (Homopolymer of Compound 1)
: 50 ml 둥근플라스크를 설치 후 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산 750 mg을 N,N-디메틸아세트아미드 30 ml에 용해시키고 실온에서 10분간 교반하였다. 여기에 AIBN 20 mg을 넣고 70 ℃에서 4시간 반응시킨 다음 실온으로 냉각시켰다. 미리 준비한 차가운 물 100 ml에 상기 반응액을 서서히 가하고 실온에서 30분간 교반한 다음 여과하여 결정체를 수득하였다. 이를 건조하여 화학식 2의 중합체를 수득하였다. : 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-hep after installing a 50 ml round flask Tenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid 750 mg was dissolved in 30 ml of N, N-dimethylacetamide and stirred at room temperature for 10 minutes. 20 mg of AIBN was added thereto, reacted at 70 ° C. for 4 hours, and then cooled to room temperature. The reaction solution was slowly added to 100 ml of cold water prepared in advance, stirred at room temperature for 30 minutes, and then filtered to obtain crystals. It was dried to obtain a polymer of formula (2).
제조예Manufacturing example 2-16 2-16
화학식 3의 중합체 제조(화학식 1의 화합물을 단량체로 한 공중합체)Preparation of Polymer of Formula 3 (Copolymer Using Compound of Formula 1 as Monomer)
: 50 ml 둥근플라스크를 설치 후 1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산 0.5 g(1.251 mmol)을 N,N-디메틸포름아미드 30 ml에 녹인 후 실온에서 10분간 교반하였다. 여기에 아크릴릭산 10 g(138.77 mmol)을 가하여 실온에서 10분간 교반한 다음 벤조일퍼옥사이드 0.05 g을 서서히 적가하였다. 이후 80 ℃로 승온하여 4시간 반응시키고, 실온으로 냉각시켰다. 미리 준비한 차가운 물 100 ml을 교반하면서 반응액을 서서히 가하고, 고체를 여과한 후 건조시켜 화합물을 수득하였다.: 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6- after installing a 50 ml round flask Heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid 0.5 g (1.251 mmol) was dissolved in 30 ml of N, N-dimethylformamide and stirred at room temperature for 10 minutes. 10 g (138.77 mmol) of acrylic acid was added thereto, stirred at room temperature for 10 minutes, and 0.05 g of benzoyl peroxide was slowly added dropwise. Then, the mixture was heated up to 80 ° C. for 4 hours, and cooled to room temperature. The reaction solution was slowly added while stirring 100 ml of previously prepared cold water, and the solid was filtered and dried to obtain a compound.
제조예Manufacturing example 2-17 내지 2-20 2-17 to 2-20
화학식 1의 화합물이 결합된 폴리올 화합물의 제조Preparation of Polyol Compound Incorporating Compound of Formula 1
: 50 ml 둥근 삼구 플라스크를 설치 후 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피퍼라진일]-4-옥소-3-퀴놀린카복실산 0.840 mg을 벤젠 30 ml에 넣고, 50 ℃에서 용해시킨 다음 2,4-톨루엔디이소시아네이트 0.635 mg 및 디부틸틴디올레이트(DBTDL) 0.01 mg을 가하여 60 ℃에서 2시간 교반하였다. 반응물에 이소프로필알콜 0.213 mg을 가하고, 60 ℃에서 5시간 동안 교반하여 반응을 완료시켰다. 반응 온도를 실온으로 냉각한 후 반응 용매를 감압 증류하여 제거하였고, 크로마토그라피(20 mg silica, 10% 에틸아세테이트/헥산)를 실시하여 항균성 화합물을 수득하였다.: 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6- after installing a 50 ml round three-necked flask 0.840 mg of heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid was added to 30 ml of benzene, dissolved at 50 ° C, and then 0.635 mg of 2,4-toluenediisocyanate and dibutyltindiolate ( DBTDL) 0.01 mg was added and stirred at 60 ° C. for 2 hours. 0.213 mg of isopropyl alcohol was added to the reaction, followed by stirring at 60 ° C. for 5 hours to complete the reaction. After the reaction temperature was cooled to room temperature, the reaction solvent was removed by distillation under reduced pressure, and chromatographed (20 mg silica, 10% ethyl acetate / hexane) was carried out to obtain an antimicrobial compound.
이어서, 상기 화합물을 폴리올과 혼합하여 반응시켜 폴리올 화합물을 제조하였다. 이때, 상기 폴리올로는 상용품인 BURNOCK(아크릴 폴리올, 제조사: 애경화학, OH값: 17.5 몰%, Tg: 126 ℃, 불휘발분: 50 중량%), ALKYLATE(아크릴 폴리올, 제조사: 애경화학, OH값: 25 몰 %, Tg: 79 ℃, 불휘발분: 50 중량 %), 045-093(알키드 폴리올, 제조사: 애경화학, OH값: 80 몰%, Tg: 97 ℃, 불휘발분: 55 중량 %), 및 아크릴(아크릴 폴리올, 제조사: 국도화학, OH값: 23 몰%, Tg: 89 ℃, 불휘발분: 50 중량 %)를 사용하여 제조하였다.
Then, the compound was mixed with the polyol and reacted to prepare a polyol compound. At this time, the polyol is a commercial article BURNOCK (acrylic polyol, manufacturer: Aekyung Chemical, OH value: 17.5 mol%, Tg: 126 ℃, non-volatile content: 50% by weight), ALKYLATE (acrylic polyol, manufacturer: Aekyung Chemical, OH Value: 25 mol%, Tg: 79 ° C., non-volatile content: 50 weight%), 045-093 (alkyd polyol, manufacturer: Aekyung Chemical, OH value: 80 mol%, Tg: 97 ° C., non-volatile content: 55 weight%) And acrylic (acrylic polyol, manufacturer: Kukdo Chemical, OH value: 23 mol%, Tg: 89 ° C., nonvolatile content: 50 wt%).
실시예Example 1 One
금속실리케이트계 바인더 수지(제조사: 영일화성, 제품명: ECO-100) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.5 parts by weight of the silica-titania composite compound according to Preparation Example 1-1, and 1 weight of Compound according to Preparation Example 2-1 based on 100 parts by weight of the metal silicate-based binder resin (manufacturer: Youngil Chemical, product name: ECO-100) The parts were mixed. To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 2 2
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-2에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, Product Name: Platop), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-1 and 1 part by weight of the compound according to Preparation Example 2-2 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 3 3
에폭시계 바인더 수지(제조사: 제비 페인트, 제품명: 에포맥스) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-3에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of epoxy binder resin (manufacturer: swallow paint, product name: Epomax), 5 parts by weight of the silica-titania composite compound according to Production Example 1-1, and 1 part by weight of the compound according to Production Example 2-3 were mixed. It was. To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 4 4
우레탄계 바인더 수지(제조사: 노루 페인트, 제품명: 그린니스) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-4에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of the urethane-based binder resin (manufacturer: roe deer paint, product name: Greenness), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-1 and 1 part by weight of the compound according to Preparation Example 2-4 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 5 5
알키드계 바인더 수지(제조사: 노루 페인트, 제품명: 에나멜) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-5에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of an alkyd binder resin (manufacturer: roe deer paint, product name: enamel), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-1, and 1 part by weight of the compound according to Preparation Example 2-5 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 6 6
우레아멜라민계 바인더 수지(제조사: 애경화학, 제품명: Au-171-65) 100 중량부에 대하여, 제조예 1-1에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-6에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of urea melamine-based binder resin (manufacturer: Aekyung Chemical, product name: Au-171-65), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-1, and the compound according to Preparation Example 2-6 1 part by weight was mixed. To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 7 7
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 1-2에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, Product Name: Platope), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-2, and 1 part by weight of the compound according to Preparation Example 2-1 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실시예Example 8 8
아크릴계 바인더 수지(제조사: 월드인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 1-3에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.
To 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, Product Name: Platop), 5 parts by weight of the silica-titania composite compound according to Production Examples 1-3 and 1 part by weight of the compound according to Production Example 2-1 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
비교예Comparative example 1 One
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 1-4에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, Product Name: Platop), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-4 and 1 part by weight of the compound according to Preparation Example 2-1 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
비교예Comparative example 2 2
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 1-5에 따른 실리카-티타니아 복합화합물 5 중량부, 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.To 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, Product Name: Platope), 5 parts by weight of the silica-titania composite compound according to Preparation Example 1-5, and 1 part by weight of the compound according to Preparation Example 2-1 were mixed. . To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
비교예Comparative example 3 3
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 실리카(SiO2) 8 중량부, 티타니아(TiO2) 2 중량부 및 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.8 parts by weight of silica (SiO 2 ), 2 parts by weight of titania (TiO 2 ) and 1 part by weight of the compound according to Preparation Example 2-1 were mixed with 100 parts by weight of the acrylic binder resin (manufacturer: World Industry, Product Name: Platope). It was. To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
비교예Comparative example 4 4
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 제조예 2-1에 따른 화합물 1 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.1 part by weight of the compound according to Production Example 2-1 was mixed with 100 parts by weight of the acrylic binder resin (manufacturer: World Industry, Product Name: Platope). To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
비교예Comparative example 5 5
아크릴계 바인더 수지(제조사: 월드 인더스트리, 제품명: 플라톱) 100 중량부에 대하여, 은나노 화합물(제조사: 이앤비코리아, 제품명: NSSE) 10 중량부를 혼합하였다. 여기에 상기 바인더 수지 100 중량부에 대하여 증점제, 안정제, 분산제 등의 첨가제 5 중량부를 첨가하여 1 시간 동안 교반하여 도료 조성물을 제조하였다.
10 parts by weight of a silver nano compound (manufactured by E & B Korea, product name: NSSE) was mixed with 100 parts by weight of an acrylic binder resin (manufacturer: World Industries, product name: platop). To the 100 parts by weight of the binder resin, 5 parts by weight of an additive such as a thickener, a stabilizer, and a dispersant were added thereto, followed by stirring for 1 hour to prepare a coating composition.
실험예Experimental Example 1 One
실시예 1, 실시예 2, 실시예 3, 실시예 4, 실시예 6, 및 비교예 5에 따른 각각의 도료 조성물을 사용하여 항곰팡이 실험 및 항세균 실험을 ASTM G21 방법(Inhibition Zone Test)으로 실시하였고, 그 결과를 하기 표 1에 나타내었다.Antifungal and antibacterial tests were carried out using ASTM G21 method (Inhibition Zone Test) using the respective coating compositions according to Examples 1, 2, 3, 4, 6 and Comparative Example 5. It carried out, and the results are shown in Table 1 below.
누룩곰팡이
(KCTC6942) A. Niger
Yeast mold
(KCTC6942)
푸른곰팡이
(KCTC6549) P. citrinum
Blue mold
(KCTC6549)
대장균
(KCTC1682) E. coli
Escherichia coli
(KCTC1682)
살모넬라균
(KCTC1925) S. typhimurium
Salmonella
(KCTC1925)
황색포도상구균
(KCTC1916) S. aureus
Staphylococcus aureus
(KCTC1916)
실험예Experimental Example 2 2
실시예 1~6 및 비교예 5에 따른 각각의 도료 조성물을 사용하여 각각 항곰팡이 실험 및 항세균 실험을 ASTM G22 방법(진탕플라스크법, Shake Flask method)으로 실시하였고, 그 결과를 하기 표 2에 나타내었다.Using the respective paint compositions according to Examples 1 to 6 and Comparative Example 5, the antifungal test and the antibacterial test were carried out by ASTM G22 method (Shake Flask method), and the results are shown in Table 2 below. Indicated.
실험예 3Experimental Example 3
실시예 1, 7, 8 및 비교예 1, 2, 4에 따른 각각의 도료 조성물에 대하여 자율 조습 특성을 평가하였다. The autonomous humidity characteristics of each coating composition according to Examples 1, 7, 8 and Comparative Examples 1, 2 and 4 were evaluated.
이때 상기 물성 측정을 위한 시편은 상기 도료를 10cmХ10cm의 유리판에 바코터(bar coater)를 사용하여 150 ㎛로 코팅한 후, 12 시간 동안 상온에 방치하여 경화시키는 방법으로 제조한 후, 상기 시편을 40 % 습도가 유지되는 항온항습기에 24 시간 방치 후 무게를 측정하였다.At this time, the test piece for measuring the physical properties of the coating on the glass plate of 10cmХ10cm using a bar coater (bar coater) to 150 ㎛, and then prepared by a method of curing by leaving at room temperature for 12 hours, the specimen 40 The weight was measured after standing for 24 hours in a thermo-hygrostat that maintains% humidity.
그 후 상기 시편을 80 % 습도가 유지되는 항온항습기에 24 시간 방치한 후 흡습량을 측정하였고, 다시 상기 시편을 40 % 습도를 유지하는 항온항습기에 24시간 유지한뒤 방습량을 측정하였다.Thereafter, the specimen was placed in a constant temperature and humidity chamber maintained at 80% humidity for 24 hours, and then the moisture absorption was measured. Then, the specimen was kept in a constant temperature and humidity chamber maintained at 40% humidity for 24 hours and then measured for moisture resistance.
여기서 상기 흡습량은 시작시편을 기준으로 한 흡습량을 의미하며(즉, 흡습량=[(흡습시편-시작시편)/단위면적), 상기 방습량은 흡습시편을 기준으로 한 방습량을 의미한다(즉, 방습량=[(흡습시편-방습시편)/단위면적).Here, the moisture absorption amount refers to the moisture absorption amount based on the start specimen (that is, moisture absorption amount = [(moisture absorption specimen-starting specimen) / unit area), and the moisture absorption amount means moisture absorption amount based on the moisture absorption specimen. (I.e. moisture proof amount = [(moisture-absorbent specimen-moisture-proof specimen) / unit area).
상기 표 4에서 알 수 있는 바와 같이, 실리카-티타니아 복합체를 포함하는 실시예 1, 7, 및 8, 및 비교예 1 및 2의 도료 조성물은 실리카-티타니아 복합체를 첨가하지 않은 비교예 4의 도료 조성물과 비교하여 흡습 및 방습 효과가 우수하였다. 또한, 실리카-티타니아 복합체 내의 Si:Ti의 몰비율이 6.5:3.5인 비교예 1의 경우에는 흡습 및 방습 효과가 좋지 않은 것으로 나타나서, 우수한 흡습 및 방습 효과를 얻기 위해서는 실리카-티타니아 복합체 내의 Si 함량이 일정 수준 이상이어야 함을 알 수 있다. 또한, 실리카-티타니아 복합체 내의 Si:Ti의 몰비율이 9.5:0.5인 비교예 2의 경우에는 Si 함량이 높아서 흡습 및 방습 효과가 우수하였으나, 아래 실험예 4에서 나타나는 바와 같이, Ti 함량이 낮음으로써 휘발성 유기화합물의 흡착 및 분해 효능이 떨어지는 것으로 나타났다.
As can be seen in Table 4, the coating compositions of Examples 1, 7, and 8, and Comparative Examples 1 and 2, including the silica-titania composite, did not add the silica-titania composite. Compared with the moisture absorption and moisture proof effect was excellent. In addition, in the case of Comparative Example 1 in which the molar ratio of Si: Ti in the silica-titania composite was 6.5: 3.5, it was found that the moisture absorption and moisture damping effect was not good. It can be seen that it must be above a certain level. In addition, in the case of Comparative Example 2 in which the molar ratio of Si: Ti in the silica-titania composite was 9.5: 0.5, the Si content was high, so that the moisture absorption and moistureproof effect was excellent. Adsorption and decomposition efficiency of volatile organic compounds was found to be inferior.
실험예Experimental Example 4 4
실시예 1, 7, 8 및 비교예 1, 2, 4에 따른 각각의 도료 조성물에 대하여 휘발성 유기화합물의 흡착 및 분해 특성을 평가하였다. 이때 샘플은 상기 제조된 도료를 10cmХ10cm의 유리판에 바코터(bar coater)를 사용하여 150 ㎛ 로 코팅한뒤 12시간 상온에 방치하여 경화시켜 각각의 준비하였으며, 밀폐된 챔버에 포름알데히드 500 ppm과 시편을 비치한 뒤 포름알데히드의 감소율을 측정하였고, 그 결과를 하기 표 5에 나타내었다.Adsorption and decomposition characteristics of volatile organic compounds were evaluated for the respective coating compositions according to Examples 1, 7, 8 and Comparative Examples 1, 2, and 4. At this time, the samples were prepared by coating the prepared paint on a glass plate of 10cmХ10cm using a bar coater (bar coater) at 150 μm and then curing them by standing at room temperature for 12 hours, and preparing 500 ppm of formaldehyde and a specimen in a sealed chamber. After the reduction of formaldehyde was measured, the results are shown in Table 5 below.
상기 표 5에서 알 수 있는 바와 같이, 실리카-티타니아 복합체를 포함하는 실시예 1, 7, 및 8의 도료 조성물은 실리카-티타니아 복합체를 첨가하지 않은 비교예 4의 도료 조성물과 비교하여 휘발성 유기화합물의 흡착 및 분해 효과가 우수하였다. 또한, 실리카-티타니아 복합체 내의 Si:Ti의 몰비율이 9.5:0.5인 비교예 2의 경우에는 흡습 및 방습 효과는 우수하지만 (표 4 참조), 휘발성 유기화합물의 흡착 및 분해 효과가 실리카-티타니아 복합체를 첨가하지 않은 비교예 4와 별 차이가 없을 정도로 좋지 않은 것으로 나타나서, 우수한 휘발성 유기화합물의 흡착 및 분해 효과를 얻기 위해서는 실리카-티타니아 복합체 내의 Ti 함량이 일정 수준 이상이어야 함을 알 수 있다. 또한, 실리카-티타니아 복합체 내의 Si:Ti의 몰비율이 6.5:3.5인 비교예 1의 경우에는 Ti 함량이 높아서 휘발성 유기화합물의 흡착 및 분해 효과가 우수하였으나, 상기 실험예 3에서 나타낸 바와 같이, Si 함량이 낮음으로써 흡습 및 방습 효능이 떨어지는 것으로 나타났다.As can be seen in Table 5, the coating compositions of Examples 1, 7, and 8 containing silica-titania composites were compared with those of Comparative Example 4 without the addition of silica-titania composites of volatile organic compounds. Adsorption and decomposition effects were excellent. In addition, in Comparative Example 2 in which the molar ratio of Si: Ti in the silica-titania composite was 9.5: 0.5, the moisture absorption and moisture damping effect was excellent (see Table 4), but the adsorption and decomposition effect of the volatile organic compound had a silica-titania composite. It is shown that it is not so good that there is no difference with Comparative Example 4 not added, it can be seen that the Ti content in the silica-titania composite must be a certain level or more in order to obtain the adsorption and decomposition effect of the excellent volatile organic compounds. In addition, in Comparative Example 1 in which the molar ratio of Si: Ti in the silica-titania composite was 6.5: 3.5, the Ti content was high, so that the adsorption and decomposition effects of volatile organic compounds were excellent, but as shown in Experimental Example 3, The low content was found to be ineffective in absorbing moisture and moisture.
표 4와 표 5의 결과를 종합하면, 실리카-티타니아 복합체를 사용함으로써 우수한 자율 조습 능력과 우수한 휘발성 유기화합물 흡착 및 분해 효능을 동시에 달성하기 위해서는, 실리카-티타니아 복합체 내의 Si와 Ti 간의 몰비가 적정한 범위로 조절될 것이 필요하며, 이들 간 몰비가 본 발명의 실시예 1 (Si:Ti=8:2), 실시예 7 (Si:Ti=7:3), 및 실시예 8 (Si:Ti=9:1) 범위인 경우 우수한 자율 조습 능력과 우수한 휘발성 유기화합물 흡착 및 분해 효능을 동시에 달성할 수 있음을 알 수 있다.
According to the results of Table 4 and Table 5, the molar ratio between Si and Ti in the silica-titania composite is appropriate in order to simultaneously achieve the excellent self-regulating ability and the adsorption and decomposition efficiency of the volatile organic compound by using the silica-titania composite. And the molar ratio between them is shown in Example 1 (Si: Ti = 8: 2), Example 7 (Si: Ti = 7: 3), and Example 8 (Si: Ti = 9) of the present invention. In the case of the range (1), it can be seen that it is possible to simultaneously achieve excellent self-humidifying ability and excellent volatile organic compound adsorption and decomposition efficiency.
실험예Experimental Example 5 5
실리카-티타니아 복합화합물을 포함하는 실시예 1과 실리카 및 티타니아의 단순 혼합물을 포함하는 비교예 3에 따른 각각의 도료 조성물에 대하여 자율 조습 특성 및 휘발성 유기화합물의 흡착 및 분해 특성을 평가하였다. For each coating composition according to Example 1 comprising a silica-titania composite compound and Comparative Example 3 comprising a simple mixture of silica and titania, self-humidifying properties and adsorption and decomposition properties of volatile organic compounds were evaluated.
이때 상기 물성 측정을 위한 시편은 상기 도료를 10cmХ10cm의 유리판에 바코터(bar coater)를 사용하여 150 ㎛로 코팅한 후, 12 시간 동안 상온에 방치하여 경화시키는 방법으로 제조한 후, 상기 시편을 40 % 습도가 유지되는 항온항습기에 24 시간 방치 후 무게를 측정하였다.At this time, the test piece for measuring the physical properties of the coating on the glass plate of 10cmХ10cm using a bar coater (bar coater) to 150 ㎛, and then prepared by a method of curing by leaving at room temperature for 12 hours, the specimen 40 The weight was measured after standing for 24 hours in a thermo-hygrostat that maintains% humidity.
그 후 상기 시편을 80 % 습도가 유지되는 항온항습기에 24 시간 방치한 후 흡습량을 측정하였고, 다시 상기 시편을 40 % 습도를 유지하는 항온항습기에 24시간 유지한뒤 방습량을 측정하였다. 여기서 상기 흡습량은 시작시편을 기준으로 한 흡습량을 의미하며(즉, 흡습량=[(흡습시편-시작시편)/단위면적), 상기 방습량은 흡습시편을 기준으로 한 방습량을 의미한다(즉, 방습량=[(흡습시편-방습시편)/단위면적).Thereafter, the specimen was placed in a constant temperature and humidity chamber maintained at 80% humidity for 24 hours, and then the moisture absorption was measured. Then, the specimen was kept in a constant temperature and humidity chamber maintained at 40% humidity for 24 hours and then measured for moisture resistance. Here, the moisture absorption amount refers to the moisture absorption amount based on the start specimen (that is, moisture absorption amount = [(moisture absorption specimen-starting specimen) / unit area), and the moisture absorption amount means moisture absorption amount based on the moisture absorption specimen. (I.e. moisture proof amount = [(moisture-absorbent specimen-moisture-proof specimen) / unit area).
또한, 밀폐된 챔버에 포름알데히드 500 ppm과 시편을 비치한 뒤 포름알데히드의 감소율을 측정하였고, 그 결과를 하기 표 6에 나타내었다.In addition, after the formaldehyde 500 ppm and the specimen in a closed chamber was measured the reduction rate of formaldehyde, the results are shown in Table 6 below.
상기 표 1 내지 표 6에 나타낸 바와 같이, 비교예 중 실리카-티타니아 복합화합물을 포함하더라도 실리콘과 티타늄의 몰비가 바람직한 범위를 벗어나는 비교예 1 및 비교예 2; 실리카와 티타니아의 단순 혼합물을 포함하는 비교예 3; 실리카-티타니아 복합화합물을 포함하지 않는 비교예 4는 항균 활성, 조습성 및 휘발성 유기화합물 흡착 분해 효능이 떨어지는 것으로 나타났다.As shown in Table 1 to Table 6, Comparative Example 1 and Comparative Example 2 in which the molar ratio of silicon and titanium is out of the preferred range even though the silica-titania composite compound is included in the comparative examples; Comparative Example 3 comprising a simple mixture of silica and titania; Comparative Example 4, which does not contain a silica-titania composite compound, was found to be inferior in antimicrobial activity, humidity control, and adsorptive decomposition efficiency of volatile organic compounds.
그에 비하여, 실시예 1~8에 따른 도료 조성물은 본 발명에 따른 항균성 화합물과 함께 실리콘(Si)과 티타늄(Ti)이 특정 몰비로 복합화된 복합화합물을 포함함에 따라, 비교예 1~5에 비하여, 항균 활성이 우수하였을 뿐만 아니라, 조습성이 우수하였고, 휘발성 유기화합물의 흡착 분해 효능도 우수한 것으로 나타났다.
On the contrary, the coating composition according to Examples 1 to 8 includes a composite compound in which silicon (Si) and titanium (Ti) are combined at a specific molar ratio together with the antimicrobial compound according to the present invention, compared to Comparative Examples 1 to 5 In addition, the antimicrobial activity was excellent, the humidity was excellent, and the adsorption and decomposition efficiency of volatile organic compounds was also excellent.
Claims (9)
실리콘(Si)과 티타늄(Ti)의 몰비가 7:3 내지 9:1인 실리카-티타니아 복합화합물; 및
바인더 수지
를 포함하는 도료 조성물:
[화학식 1]
상기 화학식 1에서,
R1은 10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실, 2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일, 2-히드록시-3-(4-노닐페녹시)프로필, 3-도데카플루오로-2-히드록시-4-옥사운데실, 2-히드록시-3-(메톡시)페녹시프로필, 2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필, 1-옥소-2-프로펜일, 또는 2-메틸-1-옥소-2-프로펜일 이고;
R2 및 R3는 각각 독립적으로 수소기 또는 메틸기이고;
R4 및 R5는 각각 독립적으로 수소기 또는 플루오르기이며;
R6는 수소기, 에틸기, 씨클로프로필기 또는 2,4-디플루오르페닐기이고;
R7은 수소기, 메틸기 또는 아미노기이며;
R8, R9 및 R10은 각각 독립적으로 탄소 또는 질소이다.At least one compound selected from the group consisting of a compound of Formula 1, a polymer compound comprising a compound of Formula 1 as a repeating unit, and a polyol compound having a compound of Formula 1;
A silica-titania composite compound having a molar ratio of silicon (Si) and titanium (Ti) 7: 3 to 9: 1; And
Binder resin
Coating composition comprising:
[Formula 1]
In Chemical Formula 1,
R 1 is 10,11-epoxy-2,6-dihydroxy-4,8-dioxoundecyl, 2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl, 2- Hydroxy-3- (4-nonylphenoxy) propyl, 3-dodecafluoro-2-hydroxy-4-oxoundecyl, 2-hydroxy-3- (methoxy) phenoxypropyl, 2-hydroxy Oxy-3- (toluene-4-sulfonyloxy) -propyl, 1-oxo-2-propenyl, or 2-methyl-1-oxo-2-propenyl;
R 2 and R 3 are each independently hydrogen or methyl;
R 4 and R 5 are each independently hydrogen or fluorine;
R 6 is a hydrogen group, an ethyl group, a cyclopropyl group or a 2,4-difluorophenyl group;
R 7 is a hydrogen group, a methyl group or an amino group;
R 8 , R 9 and R 10 are each independently carbon or nitrogen.
상기 바인더 수지 100 중량부에 대하여;
상기 화학식 1의 화합물, 상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물, 및 상기 화학식 1의 화합물이 결합된 폴리올 화합물로 이루어진 군에서 선택되는 1종 이상의 화합물 0.1 내지 20 중량부; 및
상기 실리카-티타니아 복합화합물 0.1 내지 20 중량부
를 포함하는 도료 조성물.The method of claim 1,
100 parts by weight of the binder resin;
0.1 to 20 parts by weight of at least one compound selected from the group consisting of a compound of Formula 1, a polymer compound comprising a compound of Formula 1 as a repeating unit, and a polyol compound to which the compound of Formula 1 is bonded; And
0.1 to 20 parts by weight of the silica-titania composite compound
Coating composition comprising a.
상기 실리카-티타니아 복합화합물은 실리콘(Si)과 티타늄(Ti)의 몰비가 7.5:2.5 내지 8.5:1.5인 것인 도료 조성물.The method of claim 1,
The silica-titania composite compound has a molar ratio of silicon (Si) and titanium (Ti) of 7.5: 2.5 to 8.5: 1.5.
상기 화학식 1의 화합물은 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(10,11-에폭시-2,6-디히드록시-4,8-디옥사운데실)-3-메틸-1-피페라진일]-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-{4-[2-히드록시-3-(4-노닐페녹시)프로필]-1-피페라진일}-5-옥소피리도[2,3-d]피리미딘-6-카복실산, 시스-5-아미노-1-사이클로프로필-6,8-디플루오로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-3,5-디메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-(2,4-디플루오로페닐)-6-플루오로-1,4-디히드로-7-[4-(2-히드록시-5-메틸-4-옥사-5-옥소-6-헵텐일)-3-메틸-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-사이클로프로필-6-플루오로-7-[4-(3-도데카플루오로-2-히드록시-4-옥사운데실)-3-메틸-1-피페라진일]-1,4-디히드로-5-메틸-4-옥소-3-퀴놀린카복실산, 1-에틸-6,8-디플로로-1,4-디히드로-7-{4-[2-히드록시-3-(메톡시)페녹시프로필}-3-메틸-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-{4-[2-히드록시-3-(톨루엔-4-설포닐옥시)-프로필]-1-피페라진일}-4-옥소-3-퀴놀린카복실산, 1-싸이클로프로필-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피퍼라진일]-4-옥소-3-퀴놀린카복실산, 8-에틸-5,8-디히드로-2-[4-(2-히드록시-6-메틸-4-옥사-5-옥소-6-헵텐일)-1-피페라진일]-5-옥소--피리도[2,3-d]피리미딘-6-카복실산, 1-에틸-6-플로로-1,4-디히드로-7-[4-(1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산, 및 1-사이클로프로필-6-플루오로-1,4-디히드로-7-[4-(2-메틸-1-옥소-2-프로펜일)-1-피페라진일]-4-옥소-3-퀴놀린카복실산으로 이루어진 군에서 선택되는 1종 이상의 화합물인 도료 조성물.The method of claim 1,
The compound of Formula 1 is 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (10,11-epoxy-2,6-dihydroxy-4,8-dioxone Sil) -3-methyl-1-piperazinyl] -5-methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7- [4 -(2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 8-ethyl-5 , 8-dihydro-2- {4- [2-hydroxy-3- (4-nonylphenoxy) propyl] -1-piperazinyl} -5-oxopyrido [2,3-d] pyrimidine -6-carboxylic acid, cis-5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa- 5-oxo-6-heptenyl) -3,5-dimethyl-1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1- (2,4-difluorophenyl) -6-fluoro- 1,4-dihydro-7- [4- (2-hydroxy-5-methyl-4-oxa-5-oxo-6-heptenyl) -3-methyl-1-piperazinyl] -4-oxo 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-7- [4- (3-dodecapel Luoro-2-hydroxy-4-oxoundecyl) -3-methyl-1-piperazinyl] -1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid, 1-ethyl- 6,8-difluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (methoxy) phenoxypropyl} -3-methyl-1-piperazinyl} -4- Oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- {4- [2-hydroxy-3- (toluene-4-sulfonyloxy) -propyl] -1 -Piperazinyl} -4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-hydroxy-6-methyl-4-oxa -5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (2 -Hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid, 8-ethyl-5,8-dihydro-2 -[4- (2-hydroxy-6-methyl-4-oxa-5-oxo-6-heptenyl) -1-piperazinyl] -5-oxo-pyrido [2,3-d] pyri Midine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7- [4- (1-oxo-2-propenyl) -1-pi Ferrazinyl] -4-oxo-3-quinolinecarboxylic acid, and 1-cyclopropyl-6-fluoro-1,4-dihydro-7- [4- (2-methyl-1-oxo-2-propenyl) -1-piperazinyl] -4-oxo-3-quinolinecarboxylic acid is a coating composition which is at least one compound selected from the group consisting of.
상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 2로 표시되는 것인 도료 조성물:
[화학식 2]
상기 화학식 2에서,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고,
n은 분자량을 만족하게 하는 양의 정수이다.The method of claim 1,
A high molecular weight compound comprising the compound of Formula 1 as a repeating unit has a weight average molecular weight of 10,000 to 1,000,000 and is represented by the following Chemical Formula 2:
(2)
In Formula 2,
R 1 to R 10 are the same as defined in Formula 1,
n is a positive integer satisfying the molecular weight.
상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 3으로 표시되는 랜덤 공중합체 또는 블록 공중합체인 도료 조성물:
[화학식 3]
상기 화학식 3에서,
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같고,
Y는 주쇄가 비닐알코올, 아크릴로니트릴, 부타디엔, 아크릴릭산, 스티렌, 아크릴이미드, 메틸메타아크릴산, 메타크릴산, 비닐클로라이드, 비닐플로라이드 또는 비닐아세테이트아크릴산인 반복단위이며,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.The method of claim 1,
A polymer composition comprising the compound of Formula 1 as a repeating unit has a weight average molecular weight of 10,000 to 1,000,000 and is a random copolymer or a block copolymer represented by Formula 3 below:
(3)
In Chemical Formula 3,
R 1 to R 10 are the same as defined in Formula 1,
Y is a repeating unit whose main chain is vinyl alcohol, acrylonitrile, butadiene, acrylic acid, styrene, acrylimide, methylmethacrylic acid, methacrylic acid, vinyl chloride, vinyl fluoride or vinyl acetate acrylic acid,
n and m are positive integers satisfying the molecular weight.
상기 화학식 1의 화합물을 반복단위로 포함하는 고분자 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 4로 표시되는 랜덤 공중합체 또는 블록 공중합체인 도료 조성물:
[화학식 4]
상기 화학식 4에서,
X는 하기 화학식 a로 표시되고,
[화학식 a]
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같으며,
R11 및 R12는 각각 독립적으로 수소기 또는 메틸기이고,
R13은 에스테르, 카보닐, 아미드, 아민, 시클로알킬, 에테르, 히드록시, 카르복실산, 질소(N) 또는 산소(O)를 함유하는 탄소수 2~10의 헤테로 고리, 설포닐, 실란, 락톤 및 알데히드로 이루어진 군에서 선택되는 1종 이상의 치환기를 포함하는 탄소수 1~18의 알킬기이며,
n 및 m은 분자량을 만족하게 하는 양의 정수이다.The method of claim 1,
A polymer composition comprising the compound of Formula 1 as a repeating unit has a weight average molecular weight of 10,000 to 1,000,000 and is a random copolymer or a block copolymer represented by Formula 4 below:
[Chemical Formula 4]
In Chemical Formula 4,
X is represented by the following formula a,
(A)
R 1 to R 10 are the same as defined in Formula 1,
R 11 and R 12 are each independently a hydrogen group or a methyl group,
R 13 is a heterocyclic ring having 2 to 10 carbon atoms, sulfonyl, silane, lactone containing ester, carbonyl, amide, amine, cycloalkyl, ether, hydroxy, carboxylic acid, nitrogen (N) or oxygen (O) And an alkyl group having 1 to 18 carbon atoms containing at least one substituent selected from the group consisting of aldehyde,
n and m are positive integers satisfying the molecular weight.
상기 화학식 1의 화합물이 결합된 폴리올 화합물은 중량평균 분자량이 10,000 내지 1,000,000이고 하기 화학식 5, 화학식 6, 화학식 7 또는 화학식 8로 표시되는 것인 도료 조성물:
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
상기 화학식 5 내지 화학식 8에서,
Z는 하기 화학식 b로 표시되고,
[화학식 b]
R1 내지 R10은 상기 화학식 1에서 정의한 바와 같다.The method of claim 1,
The polyol compound to which the compound of Formula 1 is bonded has a weight average molecular weight of 10,000 to 1,000,000 and is represented by the following Chemical Formula 5, Chemical Formula 6, Chemical Formula 7 or Chemical Formula 8:
[Chemical Formula 5]
[Chemical Formula 6]
(7)
[Chemical Formula 8]
In Chemical Formulas 5 to 8,
Z is represented by the following formula b,
[Formula b]
R 1 to R 10 are the same as defined in Chemical Formula 1.
상기 바인더 수지는 에폭시계 수지, 우레탄계 수지, 아크릴계 수지, 알키드계 수지, 우레아멜라민계 수지, 및 금속실리케이트계 수지로 이루어진 군에서 선택되는 1종 이상인 도료 조성물.
The method of claim 1,
The binder resin is at least one coating composition selected from the group consisting of epoxy resins, urethane resins, acrylic resins, alkyd resins, urea melamine resins, and metal silicate resins.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110003667A KR101199542B1 (en) | 2011-01-13 | 2011-01-13 | Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110003667A KR101199542B1 (en) | 2011-01-13 | 2011-01-13 | Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120082272A true KR20120082272A (en) | 2012-07-23 |
KR101199542B1 KR101199542B1 (en) | 2012-11-12 |
Family
ID=46714131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110003667A Active KR101199542B1 (en) | 2011-01-13 | 2011-01-13 | Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101199542B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106084164A (en) * | 2016-06-12 | 2016-11-09 | 四川大学 | A kind of preparation method of structure antimicrobial form polyurethane chain extender |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100536551B1 (en) | 2002-01-31 | 2005-12-14 | (주)마이크로 사이언스 테크 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
-
2011
- 2011-01-13 KR KR1020110003667A patent/KR101199542B1/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106084164A (en) * | 2016-06-12 | 2016-11-09 | 四川大学 | A kind of preparation method of structure antimicrobial form polyurethane chain extender |
Also Published As
Publication number | Publication date |
---|---|
KR101199542B1 (en) | 2012-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6613391B2 (en) | 2- (2,4-difluorophenyl) -1,1-difluoro-1- (5-substituted pyridin-2-yl) -3- (1H-tetrazol-1-yl) propan-2-ol and process for its preparation | |
MY156034A (en) | Mesoionic pesticides | |
CN101744002B (en) | Silicon-zinc mesoporous material silver-carrying antibacterial agent and preparation method thereof | |
MX2012001651A (en) | Mesoionic pesticides. | |
WO2003064412A1 (en) | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | |
NO20081180L (en) | Oxazolidinone-quinolone hybrids as antibacterial compounds | |
Jyothi et al. | Synthesis and antimicrobial activity of some novel chalcones of 3-acetyl pyridine and their pyrimidine derivatives | |
CN103880397B (en) | Diatomite ceramic and preparation method thereof | |
KR101538161B1 (en) | Eco-friendly paint compositions | |
JP5870437B2 (en) | Environmentally-friendly water-based paint composition for interior finishing materials of buildings | |
KR101052608B1 (en) | Water-based paints for indoor humidity and deodorization | |
KR101199542B1 (en) | Coating composition having improved anti-microbial activity, humidity controling performance and absorbing/decomposing performance of volatile organic compounds | |
WO2014051124A1 (en) | Photocatalytic coating composition | |
KR101207843B1 (en) | The method of treating door's handle to have antibiosis and door's handle of antibiosis treated byit | |
PT97287A (en) | PROCESS FOR THE PREPARATION OF CARBOPENEMIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
KR100536551B1 (en) | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | |
KR101554027B1 (en) | Functional paint compositions | |
CN104255777B (en) | A kind of graft on polyolefin-based materials surface antibacterial agent, its preparation method and application | |
ES2762862T3 (en) | Antibacterial glass | |
KR101299551B1 (en) | Paint for building comprising trass and method producting the same | |
KR102423141B1 (en) | Functional paint composition for non-flammable and anti-bacterial eco-friendly building finishes and construction method of eco-friendly building finishes using the same | |
WO2008110699A3 (en) | Azabicycloalkane derivatives, preparation thereof and use thereof in therapy | |
JP2008063439A (en) | Coating composition | |
KR101049418B1 (en) | Mineral composition for preventing nitric oxide and eco-friendly inorganic coating material composition | |
KR101920018B1 (en) | Environment-friendly Adhesive compositions using yellow soil stone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20110113 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20120809 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20121102 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20121102 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20151020 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20151020 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20161028 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20171102 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20171102 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20181102 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20181102 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20191002 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20191002 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20201005 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20221004 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20231004 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20241002 Start annual number: 13 End annual number: 13 |